Youluyanglu的个人主页 - 老虎社区

Youluyanglu

Youluyanglu

右禄阳禄

IP属地：未知

49关注

13粉丝

0主题

0勋章

2021-07-27

This is a no brained stock to hold and long[Miser] [Miser] [Miser] [Miser]

Tesla Is a Mature Business. Don’t Look Now.

2021-08-03

What. ePS?

Nikola Q2 adj. per-share loss 20 cents, beats loss 30 cents estimate

2021-11-01

Tesla will soon go for split again

2 Growth Stocks That Could Deliver 1,000% Returns

2021-07-27

Sales surge 98%???? Will stock price surge 10%????

Tesla shares rose more than 1% in premarket trading

2021-07-27

$Palantir Technologies Inc.(PLTR)$Always down most trading day, never up to $30 [Angry] [Angry] [Angry] [Angry]

2021-11-13

$BioNTech SE(BNTX)$Is this a falling knife stock?

2021-10-23

Buy and treat as fixed deposit worry free stock

S&P Says Tesla Inc. Upgraded To 'BB+' On Solid Demand Prospects And Robust Financial Metrics; Outlook Positive

2021-09-29

But yesterday drop more then today little increase [Spurting] [Spurting] [Spurting]

Pharmaceutical stocks rallied in morning trading

2021-06-26

$Tesla Motors(TSLA)$Bitcoin down Tesla down damn unlucky coin[Sad] [Sad] [Sad] [Sad] [Sad] [Sad] [Speechless] [Sad] [Sad] [Sad]

2021-10-02

Her ETF is under performance after bill haung and her partner left .

抱歉，原内容已删除

2021-06-08

$Tesla Motors(TSLA)$Bad news Tesla down good news Tesla still down. Bitcoin up Tesla down Bitcoin down Tesla down again

2021-08-03

$Tesla Motors(TSLA)$Go for split like last year is best. Tesla stock is too expensive for retail investors now [LOL] [LOL] [LOL]

2021-07-27

$Pinduoduo Inc.(PDD)$Will drop to $60????

2021-06-18

$Proterra Inc.(PTRA)$Why so weak after gopublic?

2021-09-21

$ARK Genomic Revolution Multi-Sector ETF(ARKG)$Worst genomic etf 2021

2021-09-13

$ARK Genomic Revolution Multi-Sector ETF(ARKG)$What is the growth 2021 YTD?

2021-09-01

$Moderna, Inc.(MRNA)$ patience

2021-07-27

$Senseonics(SENS)$Already weak for months where is the catalyst [Smug] [Smug] [Smug] [Smug] [Smug]

2021-07-22

Make no sense[Smug]

抱歉，原内容已删除

2021-12-03

Why didn’t you bought Charlie munger’s baba stock???

3 Warren Buffett Stocks I'd Buy in December Without Any Hesitation

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3560307510640662","uuid":"3560307510640662","gmtCreate":1597299768333,"gmtModify":1635040009566,"name":"Youluyanglu","pinyin":"youluyanglu","introduction":"","introductionEn":"","signature":"右禄阳禄","avatar":"https://static.tigerbbs.com/05bb06bcca1cb9cd5016f4c8230c2803","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":13,"headSize":49,"tweetSize":157,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"228c86a078844d74991fff2b7ab2428d-3","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资合伙人虎","description":"证券账户累计交易金额达到100万美元","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.05.13","exceedPercentage":"93.25%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.27","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"传说交易员","description":"证券或期货账户累计交易次数达到300次","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"93.12%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":7,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":690867711,"gmtCreate":1639656223902,"gmtModify":1639656224098,"author":{"id":"3560307510640662","authorId":"3560307510640662","name":"Youluyanglu","avatar":"https://static.tigerbbs.com/05bb06bcca1cb9cd5016f4c8230c2803","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560307510640662","authorIdStr":"3560307510640662"},"themes":[],"htmlText":"Selling from high to low? How intelligent sheis!","listText":"Selling from high to low? How intelligent sheis!","text":"Selling from high to low? How intelligent sheis!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/690867711","repostId":"1191022113","repostType":2,"repost":{"id":"1191022113","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1639626011,"share":"https://www.laohu8.com/m/news/1191022113?lang=&edition=full","pubTime":"2021-12-16 11:40","market":"us","language":"en","title":"Cathie Wood Sells Another $88M In Tesla Day After Piling Up Stake In Chinese EV Rival","url":"https://stock-news.laohu8.com/highlight/detail?id=1191022113","media":"Benzinga","summary":"Cathie Wood-led Ark Invest on Wednesday sold 90,455 shares — estimated to be worth $88.3 million — i","content":"<p><b>Cathie Wood</b>-led&nbsp;<b>Ark Invest</b>&nbsp;on Wednesday sold 90,455 shares — estimated to be worth $88.3 million — in&nbsp;<b>Tesla Inc</b>, booking profit in the stock as it rose after days of losses.</p>\n<p>The stock pared earlier losses to close&nbsp;1.82% higher at $975.99 a share on Wednesday. The Elon Musk-led company’s shares are up about 34% so far this year and down about 7.5% over the past month.</p>\n<p>Ark Invest sold the shares via the&nbsp;<b>Ark Innovation ETF</b>(BATS:ARKK), the&nbsp;<b>Ark Autonomous Technology &amp; Robotics ETF</b>(BATS:ARKQ) and the&nbsp;<b>Ark Next Generation Internet ETF</b>(BATS:ARKW)&nbsp;on Wednesday.</p>\n<p>Tesla’s weight in ARKK and ARKW had already slipped below the 10% threshold at 8.14% and 9.35%, respectively, ahead of Wednesday’s trade. In ARKQ, it constituted 10.59% of the portfolio.</p>\n<p>The three ETFs held 1.99 million shares — worth $1.91 billion — in Tesla, ahead of Wednesday’s trade.</p>\n<p>Ark Invest has been booking profit in Tesla since September — selling over $3 billion worth of shares — after years of piling up shares in the electric vehicle company at far lower levels.</p>\n<p>Tesla continues to be the firm's biggest bet across ETFs — a stock it predicts would hit the&nbsp;$3,000 mark by the end of 2025.</p>\n<p>Wood favors the automotive industry’s switch to electric vehicles and earlier thismonth started buying sharesin the U.S. listed Chinese electric automaker&nbsp;<b>Xpeng Inc</b>.</p>\n<p>Here are the other key trades on Wednesday:</p>\n<ul>\n <li>Bought 104,489 shares — estimated to be worth $21.3 million — in&nbsp;<b>Roku Inc</b>&nbsp;on the dip. The stock closed 7.95% lower at $203.94 a share on Wednesday.</li>\n <li>Bought 705,660 shares — estimated to be worth $13.7 million — in&nbsp;<b>Robinhood Markets Inc</b>. The stock closed 1.93% higher at $19.50 a share.</li>\n</ul>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cathie Wood Sells Another $88M In Tesla Day After Piling Up Stake In Chinese EV Rival</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCathie Wood Sells Another $88M In Tesla Day After Piling Up Stake In Chinese EV Rival\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-12-16 11:40</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p><b>Cathie Wood</b>-led&nbsp;<b>Ark Invest</b>&nbsp;on Wednesday sold 90,455 shares — estimated to be worth $88.3 million — in&nbsp;<b>Tesla Inc</b>, booking profit in the stock as it rose after days of losses.</p>\n<p>The stock pared earlier losses to close&nbsp;1.82% higher at $975.99 a share on Wednesday. The Elon Musk-led company’s shares are up about 34% so far this year and down about 7.5% over the past month.</p>\n<p>Ark Invest sold the shares via the&nbsp;<b>Ark Innovation ETF</b>(BATS:ARKK), the&nbsp;<b>Ark Autonomous Technology &amp; Robotics ETF</b>(BATS:ARKQ) and the&nbsp;<b>Ark Next Generation Internet ETF</b>(BATS:ARKW)&nbsp;on Wednesday.</p>\n<p>Tesla’s weight in ARKK and ARKW had already slipped below the 10% threshold at 8.14% and 9.35%, respectively, ahead of Wednesday’s trade. In ARKQ, it constituted 10.59% of the portfolio.</p>\n<p>The three ETFs held 1.99 million shares — worth $1.91 billion — in Tesla, ahead of Wednesday’s trade.</p>\n<p>Ark Invest has been booking profit in Tesla since September — selling over $3 billion worth of shares — after years of piling up shares in the electric vehicle company at far lower levels.</p>\n<p>Tesla continues to be the firm's biggest bet across ETFs — a stock it predicts would hit the&nbsp;$3,000 mark by the end of 2025.</p>\n<p>Wood favors the automotive industry’s switch to electric vehicles and earlier thismonth started buying sharesin the U.S. listed Chinese electric automaker&nbsp;<b>Xpeng Inc</b>.</p>\n<p>Here are the other key trades on Wednesday:</p>\n<ul>\n <li>Bought 104,489 shares — estimated to be worth $21.3 million — in&nbsp;<b>Roku Inc</b>&nbsp;on the dip. The stock closed 7.95% lower at $203.94 a share on Wednesday.</li>\n <li>Bought 705,660 shares — estimated to be worth $13.7 million — in&nbsp;<b>Robinhood Markets Inc</b>. The stock closed 1.93% higher at $19.50 a share.</li>\n</ul>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ARKW":"ARK Next Generation Internation ETF","HOOD":"Robinhood","XPEV":"小鹏汽车","TSLA":"特斯拉","ARKK":"ARK Innovation ETF","ARKQ":"ARK Autonomous Technology & Robotics ETF","ROKU":"Roku Inc"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1191022113","content_text":"Cathie Wood-led Ark Invest on Wednesday sold 90,455 shares — estimated to be worth $88.3 million — in Tesla Inc, booking profit in the stock as it rose after days of losses.\nThe stock pared earlier losses to close 1.82% higher at $975.99 a share on Wednesday. The Elon Musk-led company’s shares are up about 34% so far this year and down about 7.5% over the past month.\nArk Invest sold the shares via the Ark Innovation ETF(BATS:ARKK), the Ark Autonomous Technology & Robotics ETF(BATS:ARKQ) and the Ark Next Generation Internet ETF(BATS:ARKW) on Wednesday.\nTesla’s weight in ARKK and ARKW had already slipped below the 10% threshold at 8.14% and 9.35%, respectively, ahead of Wednesday’s trade. In ARKQ, it constituted 10.59% of the portfolio.\nThe three ETFs held 1.99 million shares — worth $1.91 billion — in Tesla, ahead of Wednesday’s trade.\nArk Invest has been booking profit in Tesla since September — selling over $3 billion worth of shares — after years of piling up shares in the electric vehicle company at far lower levels.\nTesla continues to be the firm's biggest bet across ETFs — a stock it predicts would hit the $3,000 mark by the end of 2025.\nWood favors the automotive industry’s switch to electric vehicles and earlier thismonth started buying sharesin the U.S. listed Chinese electric automaker Xpeng Inc.\nHere are the other key trades on Wednesday:\n\nBought 104,489 shares — estimated to be worth $21.3 million — in Roku Inc on the dip. The stock closed 7.95% lower at $203.94 a share on Wednesday.\nBought 705,660 shares — estimated to be worth $13.7 million — in Robinhood Markets Inc. The stock closed 1.93% higher at $19.50 a share.","news_type":1},"isVote":1,"tweetType":1,"viewCount":809,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":601930357,"gmtCreate":1638474281404,"gmtModify":1638474281483,"author":{"id":"3560307510640662","authorId":"3560307510640662","name":"Youluyanglu","avatar":"https://static.tigerbbs.com/05bb06bcca1cb9cd5016f4c8230c2803","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560307510640662","authorIdStr":"3560307510640662"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TDOC\">$Teladoc Health Inc.(TDOC)$</a>Next week 85?","listText":"<a href=\"https://laohu8.com/S/TDOC\">$Teladoc Health Inc.(TDOC)$</a>Next week 85?","text":"$Teladoc Health Inc.(TDOC)$Next week 85?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/601930357","isVote":1,"tweetType":1,"viewCount":776,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":601070729,"gmtCreate":1638463935686,"gmtModify":1638463935807,"author":{"id":"3560307510640662","authorId":"3560307510640662","name":"Youluyanglu","avatar":"https://static.tigerbbs.com/05bb06bcca1cb9cd5016f4c8230c2803","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560307510640662","authorIdStr":"3560307510640662"},"themes":[],"htmlText":"Why didn’t you bought Charlie munger’s baba stock???","listText":"Why didn’t you bought Charlie munger’s baba stock???","text":"Why didn’t you bought Charlie munger’s baba stock???","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/601070729","repostId":"2188124518","repostType":4,"repost":{"id":"2188124518","kind":"highlight","pubTimestamp":1638451761,"share":"https://www.laohu8.com/m/news/2188124518?lang=&edition=full","pubTime":"2021-12-02 21:29","market":"us","language":"en","title":"3 Warren Buffett Stocks I'd Buy in December Without Any Hesitation","url":"https://stock-news.laohu8.com/highlight/detail?id=2188124518","media":"Motley Fool","summary":"All three should be surefire winners over the long term.","content":"<p>Warren Buffett isn't as big of a winner as he once was. The legendary investor routinely beat the <b>S&amp;P 500</b>'s performance throughout much of his career. So far this year, though, <b>Berkshire Hathaway</b>'s (NYSE:BRK.A) (NYSE:BRK.B) gains are lagging behind the index.</p>\n<p>Many of the stocks in Berkshire's portfolio have generated strong year-to-date returns, but not all of them. Regardless of how they've performed recently, some Berkshire holdings remain especially attractive over the long term.&nbsp;Here are three Buffett stocks I'd buy in December without any reservations.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/1273c4c1c74f572c86d5fa1d36534c37\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: The Motley Fool.</span></p>\n<h2>1. Amazon.com</h2>\n<p><b>Amazon.com</b> (NASDAQ:AMZN) belongs in the group of Buffett's laggards. Shares of the internet giant have risen only around 8% this year, well behind Berkshire's overall performance. However, there are few stocks of large companies that have as clear of a growth runway as Amazon does.</p>\n<p>Let's start with the near term. Amazon expects record holiday sales in the fourth quarter of $135 billion. Twelve-digit quarterly revenue has become standard fare for the company. Amazon is investing heavily in adding capacity to support its fulfillment operations. That's an obvious sign that the company anticipates significant growth in the future.</p>\n<p>This isn't a surprise. E-commerce sales in the U.S. made up only 13% of total retail sales in the third quarter. Amazon still has a huge growth opportunity in this core market.</p>\n<p>But e-commerce is just <a href=\"https://laohu8.com/S/AONE.U\">one</a> growth driver for the company. Amazon Web Services remains the biggest cloud hosting business in the world and continues to grow rapidly. The company's advertising business is picking up major momentum. Amazon's healthcare moves in online pharmacy and telehealth could also pay off nicely. I don't see this stock staying a laggard for very long.</p>\n<h2>2. Apple</h2>\n<p>Not all of the FAANG stocks are underperformers this year. Shares of&nbsp;<b>Apple</b> (NASDAQ:AAPL) have soared more than 20%. And that impressive gain came despite the company posting disappointing Q3 results.</p>\n<p>Investors are focusing on the future with Apple -- just as they should be. The company continues to ride the wave of 5G adoption. Its iPhone sales seem likely to reach record levels this holiday season unless supply chain issues serve as a damper. The 5G \"supercycle\" could keep going throughout 2022 and even beyond.</p>\n<p>Apple could enjoy even stronger growth going forward. The company could unveil its augmented reality (AR) headset next year, and it's working on AR glasses. Apple is also reportedly developing a self-driving electric car.</p>\n<p>Buffett likes Apple so much that it's the largest holding in Berkshire's portfolio. I fully expect that the stock will keep up its winning ways for years to come.</p>\n<h2>3. Mastercard</h2>\n<p>You might be at least a little surprised that I've included&nbsp;<b>Mastercard</b> (NYSE:MA) on this list. After all, the stock has fallen more than 10% so far in 2021. But there's still a lot to like about Mastercard.</p>\n<p>The company makes money from transaction fees every time one of its credit cards is used to make a purchase. With the rise of e-commerce and the shift away from cash with in-store purchases, Mastercard's credit cards will almost certainly be used a lot more in the future.</p>\n<p>Although Mastercard is already a global company, it still has plenty of growth opportunities in developing regions. For example, Mastercard's recent acquisition of fintech company Arcus FI should help boost its presence in the Latin American market.</p>\n<p>Two potential growth drivers for Mastercard might not receive as much attention as they deserve. The company's \"buy now, pay later\" program is picking up momentum. Mastercard is also expanding its cryptocurrency support, partnering with three cryptocurrency providers in the Asia Pacific region to launch crypto-funded Mastercard payment cards.</p>\n<p>It's possible that the emergence of the omicron variant could create some temporary headwinds for Mastercard if businesses experience disruptions. However, this Buffett stock should be a big winner over the long run.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Warren Buffett Stocks I'd Buy in December Without Any Hesitation</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Warren Buffett Stocks I'd Buy in December Without Any Hesitation\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-02 21:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/02/3-warren-buffett-stocks-id-buy-in-december-without/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Warren Buffett isn't as big of a winner as he once was. The legendary investor routinely beat the S&P 500's performance throughout much of his career. So far this year, though, Berkshire Hathaway's (...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/02/3-warren-buffett-stocks-id-buy-in-december-without/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4507":"流媒体概念","BK4534":"瑞士信贷持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4566":"资本集团","BK4524":"宅经济概念","BRK.A":"伯克希尔","BK4535":"淡马锡持仓","BK4559":"巴菲特持仓","BK4527":"明星科技股","BRK.B":"伯克希尔B","BK4501":"段永平概念","BK4538":"云计算","BK4550":"红杉资本持仓","AMZN":"亚马逊","BK4503":"景林资产持仓","BK4122":"互联网与直销零售","BK4551":"寇图资本持仓","AR":"Antero Resources Corp","BK4561":"索罗斯持仓","AAPL":"苹果","BK4505":"高瓴资本持仓","BK4548":"巴美列捷福持仓","BK4170":"电脑硬件、储存设备及电脑周边","BK4176":"多领域控股","BK4213":"石油与天然气的勘探与生产","BK4554":"元宇宙及AR概念","BK4106":"数据处理与外包服务","BK4532":"文艺复兴科技持仓","BK4515":"5G概念","MA":"万事达","BK4553":"喜马拉雅资本持仓"},"source_url":"https://www.fool.com/investing/2021/12/02/3-warren-buffett-stocks-id-buy-in-december-without/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2188124518","content_text":"Warren Buffett isn't as big of a winner as he once was. The legendary investor routinely beat the S&P 500's performance throughout much of his career. So far this year, though, Berkshire Hathaway's (NYSE:BRK.A) (NYSE:BRK.B) gains are lagging behind the index.\nMany of the stocks in Berkshire's portfolio have generated strong year-to-date returns, but not all of them. Regardless of how they've performed recently, some Berkshire holdings remain especially attractive over the long term. Here are three Buffett stocks I'd buy in December without any reservations.\nImage source: The Motley Fool.\n1. Amazon.com\nAmazon.com (NASDAQ:AMZN) belongs in the group of Buffett's laggards. Shares of the internet giant have risen only around 8% this year, well behind Berkshire's overall performance. However, there are few stocks of large companies that have as clear of a growth runway as Amazon does.\nLet's start with the near term. Amazon expects record holiday sales in the fourth quarter of $135 billion. Twelve-digit quarterly revenue has become standard fare for the company. Amazon is investing heavily in adding capacity to support its fulfillment operations. That's an obvious sign that the company anticipates significant growth in the future.\nThis isn't a surprise. E-commerce sales in the U.S. made up only 13% of total retail sales in the third quarter. Amazon still has a huge growth opportunity in this core market.\nBut e-commerce is just one growth driver for the company. Amazon Web Services remains the biggest cloud hosting business in the world and continues to grow rapidly. The company's advertising business is picking up major momentum. Amazon's healthcare moves in online pharmacy and telehealth could also pay off nicely. I don't see this stock staying a laggard for very long.\n2. Apple\nNot all of the FAANG stocks are underperformers this year. Shares of Apple (NASDAQ:AAPL) have soared more than 20%. And that impressive gain came despite the company posting disappointing Q3 results.\nInvestors are focusing on the future with Apple -- just as they should be. The company continues to ride the wave of 5G adoption. Its iPhone sales seem likely to reach record levels this holiday season unless supply chain issues serve as a damper. The 5G \"supercycle\" could keep going throughout 2022 and even beyond.\nApple could enjoy even stronger growth going forward. The company could unveil its augmented reality (AR) headset next year, and it's working on AR glasses. Apple is also reportedly developing a self-driving electric car.\nBuffett likes Apple so much that it's the largest holding in Berkshire's portfolio. I fully expect that the stock will keep up its winning ways for years to come.\n3. Mastercard\nYou might be at least a little surprised that I've included Mastercard (NYSE:MA) on this list. After all, the stock has fallen more than 10% so far in 2021. But there's still a lot to like about Mastercard.\nThe company makes money from transaction fees every time one of its credit cards is used to make a purchase. With the rise of e-commerce and the shift away from cash with in-store purchases, Mastercard's credit cards will almost certainly be used a lot more in the future.\nAlthough Mastercard is already a global company, it still has plenty of growth opportunities in developing regions. For example, Mastercard's recent acquisition of fintech company Arcus FI should help boost its presence in the Latin American market.\nTwo potential growth drivers for Mastercard might not receive as much attention as they deserve. The company's \"buy now, pay later\" program is picking up momentum. Mastercard is also expanding its cryptocurrency support, partnering with three cryptocurrency providers in the Asia Pacific region to launch crypto-funded Mastercard payment cards.\nIt's possible that the emergence of the omicron variant could create some temporary headwinds for Mastercard if businesses experience disruptions. However, this Buffett stock should be a big winner over the long run.","news_type":1},"isVote":1,"tweetType":1,"viewCount":407,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":603800079,"gmtCreate":1638385669067,"gmtModify":1638385669311,"author":{"id":"3560307510640662","authorId":"3560307510640662","name":"Youluyanglu","avatar":"https://static.tigerbbs.com/05bb06bcca1cb9cd5016f4c8230c2803","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560307510640662","authorIdStr":"3560307510640662"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TDOC\">$Teladoc Health Inc.(TDOC)$</a>Anymore hope?!?!","listText":"<a href=\"https://laohu8.com/S/TDOC\">$Teladoc Health Inc.(TDOC)$</a>Anymore hope?!?!","text":"$Teladoc Health Inc.(TDOC)$Anymore hope?!?!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/603800079","isVote":1,"tweetType":1,"viewCount":842,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":600775661,"gmtCreate":1638201955405,"gmtModify":1638201955677,"author":{"id":"3560307510640662","authorId":"3560307510640662","name":"Youluyanglu","avatar":"https://static.tigerbbs.com/05bb06bcca1cb9cd5016f4c8230c2803","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560307510640662","authorIdStr":"3560307510640662"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BNTX\">$BioNTech SE(BNTX)$</a>Luckily run at 364","listText":"<a href=\"https://laohu8.com/S/BNTX\">$BioNTech SE(BNTX)$</a>Luckily run at 364","text":"$BioNTech SE(BNTX)$Luckily run at 364","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/600775661","isVote":1,"tweetType":1,"viewCount":774,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":875420854,"gmtCreate":1637679875594,"gmtModify":1637679875672,"author":{"id":"3560307510640662","authorId":"3560307510640662","name":"Youluyanglu","avatar":"https://static.tigerbbs.com/05bb06bcca1cb9cd5016f4c8230c2803","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560307510640662","authorIdStr":"3560307510640662"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/RIVN\">$Rivian Automotive, Inc.(RIVN)$</a>Production no scalibity how to fill the world","listText":"<a href=\"https://laohu8.com/S/RIVN\">$Rivian Automotive, Inc.(RIVN)$</a>Production no scalibity how to fill the world","text":"$Rivian Automotive, Inc.(RIVN)$Production no scalibity how to fill the world","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/875420854","isVote":1,"tweetType":1,"viewCount":645,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":875366490,"gmtCreate":1637611062173,"gmtModify":1637611062289,"author":{"id":"3560307510640662","authorId":"3560307510640662","name":"Youluyanglu","avatar":"https://static.tigerbbs.com/05bb06bcca1cb9cd5016f4c8230c2803","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560307510640662","authorIdStr":"3560307510640662"},"themes":[],"htmlText":"We","listText":"We","text":"We","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/875366490","repostId":"876938585","repostType":1,"repost":{"id":876938585,"gmtCreate":1637248228670,"gmtModify":1637248228670,"author":{"id":"3575447170954511","authorId":"3575447170954511","name":"WolfofWS","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":8,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575447170954511","authorIdStr":"3575447170954511"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TDOC\">$Teladoc Health Inc.(TDOC)$</a>What is wrong? [Facepalm]&nbsp;","listText":"<a href=\"https://laohu8.com/S/TDOC\">$Teladoc Health Inc.(TDOC)$</a>What is wrong? [Facepalm]&nbsp;","text":"$Teladoc Health Inc.(TDOC)$What is wrong? [Facepalm]","images":[{"img":"https://static.tigerbbs.com/a20c9170ef82c95a2aabb86d2f33e2e2","width":"1284","height":"2538"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/876938585","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":702,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":875002198,"gmtCreate":1637583776456,"gmtModify":1637583776537,"author":{"id":"3560307510640662","authorId":"3560307510640662","name":"Youluyanglu","avatar":"https://static.tigerbbs.com/05bb06bcca1cb9cd5016f4c8230c2803","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560307510640662","authorIdStr":"3560307510640662"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/CLOV\">$Clover Health Corp(CLOV)$</a>Luckily I sold all one month plus at $8 after d c a.","listText":"<a href=\"https://laohu8.com/S/CLOV\">$Clover Health Corp(CLOV)$</a>Luckily I sold all one month plus at $8 after d c a.","text":"$Clover Health Corp(CLOV)$Luckily I sold all one month plus at $8 after d c a.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/875002198","isVote":1,"tweetType":1,"viewCount":970,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":876318570,"gmtCreate":1637265183332,"gmtModify":1637265183332,"author":{"id":"3560307510640662","authorId":"3560307510640662","name":"Youluyanglu","avatar":"https://static.tigerbbs.com/05bb06bcca1cb9cd5016f4c8230c2803","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560307510640662","authorIdStr":"3560307510640662"},"themes":[],"htmlText":"Lesser Tesla stock low chance to win","listText":"Lesser Tesla stock low chance to win","text":"Lesser Tesla stock low chance to win","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/876318570","repostId":"852866819","repostType":1,"repost":{"id":852866819,"gmtCreate":1635257597351,"gmtModify":1635257598523,"author":{"id":"3567070024174374","authorId":"3567070024174374","name":"TrisT","avatar":"https://static.tigerbbs.com/8ed7f4b6aa33dc3d4922b2cf0b507be0","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3567070024174374","authorIdStr":"3567070024174374"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ARKW\">$ARK Next Generation Internet ETF(ARKW)$</a>after months , it finally break even","listText":"<a href=\"https://laohu8.com/S/ARKW\">$ARK Next Generation Internet ETF(ARKW)$</a>after months , it finally break even","text":"$ARK Next Generation Internet ETF(ARKW)$after months , it finally break even","images":[{"img":"https://static.tigerbbs.com/27a0f680abfb481d14cfd4e0ba40e639","width":"1125","height":"2196"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/852866819","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":1119,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":876318301,"gmtCreate":1637264967185,"gmtModify":1637264967303,"author":{"id":"3560307510640662","authorId":"3560307510640662","name":"Youluyanglu","avatar":"https://static.tigerbbs.com/05bb06bcca1cb9cd5016f4c8230c2803","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560307510640662","authorIdStr":"3560307510640662"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ROKU\">$Roku Inc(ROKU)$</a>Where is the most for this share?","listText":"<a href=\"https://laohu8.com/S/ROKU\">$Roku Inc(ROKU)$</a>Where is the most for this share?","text":"$Roku Inc(ROKU)$Where is the most for this share?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/876318301","isVote":1,"tweetType":1,"viewCount":672,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":879510105,"gmtCreate":1636735552212,"gmtModify":1636754295246,"author":{"id":"3560307510640662","authorId":"3560307510640662","name":"Youluyanglu","avatar":"https://static.tigerbbs.com/05bb06bcca1cb9cd5016f4c8230c2803","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560307510640662","authorIdStr":"3560307510640662"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PLTR\">$Palantir Technologies Inc.(PLTR)$</a>Hood q3earnings still fall like bird shit[Surprised]&nbsp;","listText":"<a href=\"https://laohu8.com/S/PLTR\">$Palantir Technologies Inc.(PLTR)$</a>Hood q3earnings still fall like bird shit[Surprised]&nbsp;","text":"$Palantir Technologies Inc.(PLTR)$Hood q3earnings still fall like bird shit[Surprised]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/879510105","isVote":1,"tweetType":1,"viewCount":215,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":879532663,"gmtCreate":1636734917800,"gmtModify":1636734917915,"author":{"id":"3560307510640662","authorId":"3560307510640662","name":"Youluyanglu","avatar":"https://static.tigerbbs.com/05bb06bcca1cb9cd5016f4c8230c2803","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560307510640662","authorIdStr":"3560307510640662"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BNTX\">$BioNTech SE(BNTX)$</a>Is this a falling knife stock?","listText":"<a href=\"https://laohu8.com/S/BNTX\">$BioNTech SE(BNTX)$</a>Is this a falling knife stock?","text":"$BioNTech SE(BNTX)$Is this a falling knife stock?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":1,"link":"https://laohu8.com/post/879532663","isVote":1,"tweetType":1,"viewCount":893,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":870781069,"gmtCreate":1636647401926,"gmtModify":1636647402185,"author":{"id":"3560307510640662","authorId":"3560307510640662","name":"Youluyanglu","avatar":"https://static.tigerbbs.com/05bb06bcca1cb9cd5016f4c8230c2803","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560307510640662","authorIdStr":"3560307510640662"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/CPNG\">$Coupang, Inc.(CPNG)$</a>All the way down ever since IPO","listText":"<a href=\"https://laohu8.com/S/CPNG\">$Coupang, Inc.(CPNG)$</a>All the way down ever since IPO","text":"$Coupang, Inc.(CPNG)$All the way down ever since IPO","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/870781069","isVote":1,"tweetType":1,"viewCount":215,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":847797922,"gmtCreate":1636552907903,"gmtModify":1636553012053,"author":{"id":"3560307510640662","authorId":"3560307510640662","name":"Youluyanglu","avatar":"https://static.tigerbbs.com/05bb06bcca1cb9cd5016f4c8230c2803","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560307510640662","authorIdStr":"3560307510640662"},"themes":[],"htmlText":"Burry should try not drawing salary and bonus for 10 years before he commented this.","listText":"Burry should try not drawing salary and bonus for 10 years before he commented this.","text":"Burry should try not drawing salary and bonus for 10 years before he commented this.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/847797922","repostId":"1180704879","repostType":2,"repost":{"id":"1180704879","kind":"news","pubTimestamp":1636546078,"share":"https://www.laohu8.com/m/news/1180704879?lang=&edition=full","pubTime":"2021-11-10 20:07","market":"us","language":"en","title":"Not World Hunger Or Tax Bill But This Is The Real Reason Why Elon Musk Wants To Sell Tesla Stock, As Per 'The Big Short' Fame's Michael Burry","url":"https://stock-news.laohu8.com/highlight/detail?id=1180704879","media":"Benzinga","summary":"“The Big Short” investor Michael Burry has suggested that Tesla Inc. CEO and the world’s richest per","content":"<p>“The Big Short” investor Michael Burry has suggested that Tesla Inc.&nbsp;CEO and the world’s richest person Elon Musk might be looking to sell some of his holdings in the electric vehicle maker to cover his personal debts, Business Insider reported.</p>\n<p>What Happened: Burry, who rejoined Twitter this week, noted that Musk had 88.3 million shares pledged as loan collateral, as per the report.</p>\n<p>Burry also reportedly posted a link to a regulatory filing in August that showed Musk had pledged about 88 million shares, or 36% of his total stake in Tesla, as collateral for personal loans as of June 30.</p>\n<p>The tweet - which does not currently appear on Burry’s Twitter feed - implied that Musk’s sudden interest in a stock sale was to service the loans he has taken using his Tesla stock, rather than to help solve world hunger or because he faces a huge $15 billion tax bill.</p>\n<p>Why It Matters: Tesla’s stock fell for the second straight day on Tuesday following Musk’s Twitter poll over the weekend, asking his followers whether he should sell 10% of his shares in the company. The Twitter poll was apparently prompted by a billionaires tax proposed by Oregon Senator Ron Wyden.</p>\n<p>It was reported that Musk lost a record $50 billion this week following the plunge in Tesla’s shares, citing Bloomberg.</p>\n<p>Burry is a former hedge fund manager who gained notoriety on Wall Street by predicting and profiting from the subprime mortgage crisis. He was depicted by Christian Bale in “The Big Short” movie in 2015.</p>\n<p>Burry said in December last year that he was shorting Tesla stock and is skeptical of the company’s lofty valuations.</p>\n<p>However, the famed investor said last month that he is no longer betting against Tesla and his position in the electric vehicle maker was only a trade, it was reported, citing CNBC.</p>\n<p>Price Action: Tesla shares closed almost 12% lower in Tuesday’s regular trading session at $1,023.50.</p>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Not World Hunger Or Tax Bill But This Is The Real Reason Why Elon Musk Wants To Sell Tesla Stock, As Per 'The Big Short' Fame's Michael Burry</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNot World Hunger Or Tax Bill But This Is The Real Reason Why Elon Musk Wants To Sell Tesla Stock, As Per 'The Big Short' Fame's Michael Burry\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-10 20:07 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/news/21/11/24005276/not-world-hunger-or-tax-bill-but-this-is-the-real-reason-why-elon-musk-wants-to-sell-tesla-stock-as><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>“The Big Short” investor Michael Burry has suggested that Tesla Inc. CEO and the world’s richest person Elon Musk might be looking to sell some of his holdings in the electric vehicle maker to cover ...</p>\n\n<a href=\"https://www.benzinga.com/news/21/11/24005276/not-world-hunger-or-tax-bill-but-this-is-the-real-reason-why-elon-musk-wants-to-sell-tesla-stock-as\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"source_url":"https://www.benzinga.com/news/21/11/24005276/not-world-hunger-or-tax-bill-but-this-is-the-real-reason-why-elon-musk-wants-to-sell-tesla-stock-as","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1180704879","content_text":"“The Big Short” investor Michael Burry has suggested that Tesla Inc. CEO and the world’s richest person Elon Musk might be looking to sell some of his holdings in the electric vehicle maker to cover his personal debts, Business Insider reported.\nWhat Happened: Burry, who rejoined Twitter this week, noted that Musk had 88.3 million shares pledged as loan collateral, as per the report.\nBurry also reportedly posted a link to a regulatory filing in August that showed Musk had pledged about 88 million shares, or 36% of his total stake in Tesla, as collateral for personal loans as of June 30.\nThe tweet - which does not currently appear on Burry’s Twitter feed - implied that Musk’s sudden interest in a stock sale was to service the loans he has taken using his Tesla stock, rather than to help solve world hunger or because he faces a huge $15 billion tax bill.\nWhy It Matters: Tesla’s stock fell for the second straight day on Tuesday following Musk’s Twitter poll over the weekend, asking his followers whether he should sell 10% of his shares in the company. The Twitter poll was apparently prompted by a billionaires tax proposed by Oregon Senator Ron Wyden.\nIt was reported that Musk lost a record $50 billion this week following the plunge in Tesla’s shares, citing Bloomberg.\nBurry is a former hedge fund manager who gained notoriety on Wall Street by predicting and profiting from the subprime mortgage crisis. He was depicted by Christian Bale in “The Big Short” movie in 2015.\nBurry said in December last year that he was shorting Tesla stock and is skeptical of the company’s lofty valuations.\nHowever, the famed investor said last month that he is no longer betting against Tesla and his position in the electric vehicle maker was only a trade, it was reported, citing CNBC.\nPrice Action: Tesla shares closed almost 12% lower in Tuesday’s regular trading session at $1,023.50.","news_type":1},"isVote":1,"tweetType":1,"viewCount":307,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":842334997,"gmtCreate":1636131742639,"gmtModify":1636131742913,"author":{"id":"3560307510640662","authorId":"3560307510640662","name":"Youluyanglu","avatar":"https://static.tigerbbs.com/05bb06bcca1cb9cd5016f4c8230c2803","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560307510640662","authorIdStr":"3560307510640662"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TSLA\">$Tesla Motors(TSLA)$</a>Giga Austin fast progresss","listText":"<a href=\"https://laohu8.com/S/TSLA\">$Tesla Motors(TSLA)$</a>Giga Austin fast progresss","text":"$Tesla Motors(TSLA)$Giga Austin fast progresss","images":[{"img":"https://static.tigerbbs.com/35061c7b33e3fd86a3ac589da0815aba","width":"2000","height":"1125"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/842334997","isVote":1,"tweetType":1,"viewCount":185,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":848720805,"gmtCreate":1636031169593,"gmtModify":1636031502532,"author":{"id":"3560307510640662","authorId":"3560307510640662","name":"Youluyanglu","avatar":"https://static.tigerbbs.com/05bb06bcca1cb9cd5016f4c8230c2803","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560307510640662","authorIdStr":"3560307510640662"},"themes":[],"htmlText":"Nikola got result!?!","listText":"Nikola got result!?!","text":"Nikola got result!?!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/848720805","repostId":"1100949235","repostType":4,"repost":{"id":"1100949235","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1636031029,"share":"https://www.laohu8.com/m/news/1100949235?lang=&edition=full","pubTime":"2021-11-04 21:03","market":"us","language":"en","title":"Nikola stock surged 6% after reporting quarterly results","url":"https://stock-news.laohu8.com/highlight/detail?id=1100949235","media":"Tiger Newspress","summary":"Nikola stock surged 6% after reporting quarterly results.\n\nNikola Corporation today reported financi","content":"<p>Nikola stock surged 6% after reporting quarterly results.</p>\n<p><img src=\"https://static.tigerbbs.com/eed83deb9bd3d57a85bf31a9ee1b16d7\" tg-width=\"849\" tg-height=\"618\" referrerpolicy=\"no-referrer\"></p>\n<p>Nikola Corporation&nbsp;today reported financial results for the quarter ended September 30, 2021.</p>\n<ul>\n <li><p>Up to 25 Tre BEV trucks are expected to be delivered to dealers and customers by the end of 2021 and Tre FCEV is on schedule, and testing has begun</p></li>\n <li><p>Continued progress building out the sales and service network with dealers in 28 states consisting of over 130 locations</p></li>\n <li><p>Ulm, Germany joint venture manufacturing facility inaugurated in September</p></li>\n <li><p>$125 million reserved to fund potential settlement with the SEC</p></li>\n</ul>\n<p>\"During the third quarter, we continued to execute on our business plan,” said Mark Russell, Nikola's Chief Executive Officer. “Validation of the Nikola Tre BEV is progressing, with trucks now being test-driven and tested on public roads. We also formally inaugurated our joint venture manufacturing facility in Ulm, Germany, and entered into additional strategic partnerships to advance our hydrogen refueling ecosystem with TC Energy and OPAL Fuels.”</p>\n<p>Russell added, “with prospects of an SEC settlement, we’re looking forward to resolving the outstanding issues relating to our founder and bringing that chapter to a close and maintaining our focus on delivering trucks to our customers, and building the energy, service, and support infrastructure our customers need.”</p>\n<p><b>Third Quarter Financial Highlights</b></p>\n<p><img src=\"https://static.tigerbbs.com/0c6af9593f60adb9a4fa204669090164\" tg-width=\"2994\" tg-height=\"960\" referrerpolicy=\"no-referrer\"></p>\n<p><b>Business Outlook</b></p>\n<p>Nikola looks forward to achieving the following milestones in the fourth quarter of 2021:</p>\n<ul>\n <li><p>Deliver pre-series Nikola Tre BEVs for use on public roads hauling customer freight;</p></li>\n <li><p>Announce additional fleet testing dealers/customers;</p></li>\n <li><p>Purchase land for our first centralized hydrogen production hub facility and/or commercial on-site gaseous generation station; and</p></li>\n <li><p>Announce additional hydrogen infrastructure/ecosystem partners</p></li>\n</ul>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nikola stock surged 6% after reporting quarterly results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNikola stock surged 6% after reporting quarterly results\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-11-04 21:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Nikola stock surged 6% after reporting quarterly results.</p>\n<p><img src=\"https://static.tigerbbs.com/eed83deb9bd3d57a85bf31a9ee1b16d7\" tg-width=\"849\" tg-height=\"618\" referrerpolicy=\"no-referrer\"></p>\n<p>Nikola Corporation&nbsp;today reported financial results for the quarter ended September 30, 2021.</p>\n<ul>\n <li><p>Up to 25 Tre BEV trucks are expected to be delivered to dealers and customers by the end of 2021 and Tre FCEV is on schedule, and testing has begun</p></li>\n <li><p>Continued progress building out the sales and service network with dealers in 28 states consisting of over 130 locations</p></li>\n <li><p>Ulm, Germany joint venture manufacturing facility inaugurated in September</p></li>\n <li><p>$125 million reserved to fund potential settlement with the SEC</p></li>\n</ul>\n<p>\"During the third quarter, we continued to execute on our business plan,” said Mark Russell, Nikola's Chief Executive Officer. “Validation of the Nikola Tre BEV is progressing, with trucks now being test-driven and tested on public roads. We also formally inaugurated our joint venture manufacturing facility in Ulm, Germany, and entered into additional strategic partnerships to advance our hydrogen refueling ecosystem with TC Energy and OPAL Fuels.”</p>\n<p>Russell added, “with prospects of an SEC settlement, we’re looking forward to resolving the outstanding issues relating to our founder and bringing that chapter to a close and maintaining our focus on delivering trucks to our customers, and building the energy, service, and support infrastructure our customers need.”</p>\n<p><b>Third Quarter Financial Highlights</b></p>\n<p><img src=\"https://static.tigerbbs.com/0c6af9593f60adb9a4fa204669090164\" tg-width=\"2994\" tg-height=\"960\" referrerpolicy=\"no-referrer\"></p>\n<p><b>Business Outlook</b></p>\n<p>Nikola looks forward to achieving the following milestones in the fourth quarter of 2021:</p>\n<ul>\n <li><p>Deliver pre-series Nikola Tre BEVs for use on public roads hauling customer freight;</p></li>\n <li><p>Announce additional fleet testing dealers/customers;</p></li>\n <li><p>Purchase land for our first centralized hydrogen production hub facility and/or commercial on-site gaseous generation station; and</p></li>\n <li><p>Announce additional hydrogen infrastructure/ecosystem partners</p></li>\n</ul>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NKLA":"Nikola Corporation"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1100949235","content_text":"Nikola stock surged 6% after reporting quarterly results.\n\nNikola Corporation today reported financial results for the quarter ended September 30, 2021.\n\nUp to 25 Tre BEV trucks are expected to be delivered to dealers and customers by the end of 2021 and Tre FCEV is on schedule, and testing has begun\nContinued progress building out the sales and service network with dealers in 28 states consisting of over 130 locations\nUlm, Germany joint venture manufacturing facility inaugurated in September\n$125 million reserved to fund potential settlement with the SEC\n\n\"During the third quarter, we continued to execute on our business plan,” said Mark Russell, Nikola's Chief Executive Officer. “Validation of the Nikola Tre BEV is progressing, with trucks now being test-driven and tested on public roads. We also formally inaugurated our joint venture manufacturing facility in Ulm, Germany, and entered into additional strategic partnerships to advance our hydrogen refueling ecosystem with TC Energy and OPAL Fuels.”\nRussell added, “with prospects of an SEC settlement, we’re looking forward to resolving the outstanding issues relating to our founder and bringing that chapter to a close and maintaining our focus on delivering trucks to our customers, and building the energy, service, and support infrastructure our customers need.”\nThird Quarter Financial Highlights\n\nBusiness Outlook\nNikola looks forward to achieving the following milestones in the fourth quarter of 2021:\n\nDeliver pre-series Nikola Tre BEVs for use on public roads hauling customer freight;\nAnnounce additional fleet testing dealers/customers;\nPurchase land for our first centralized hydrogen production hub facility and/or commercial on-site gaseous generation station; and\nAnnounce additional hydrogen infrastructure/ecosystem partners","news_type":1},"isVote":1,"tweetType":1,"viewCount":421,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":849653182,"gmtCreate":1635754370904,"gmtModify":1635754371016,"author":{"id":"3560307510640662","authorId":"3560307510640662","name":"Youluyanglu","avatar":"https://static.tigerbbs.com/05bb06bcca1cb9cd5016f4c8230c2803","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560307510640662","authorIdStr":"3560307510640662"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TSLA\">$Tesla Motors(TSLA)$</a>Next Monday or Tuesday Tesla board meeting. If this week the price reach 1250 high chance will split&nbsp;","listText":"<a href=\"https://laohu8.com/S/TSLA\">$Tesla Motors(TSLA)$</a>Next Monday or Tuesday Tesla board meeting. If this week the price reach 1250 high chance will split&nbsp;","text":"$Tesla Motors(TSLA)$Next Monday or Tuesday Tesla board meeting. If this week the price reach 1250 high chance will split","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/849653182","isVote":1,"tweetType":1,"viewCount":616,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":849880282,"gmtCreate":1635742012878,"gmtModify":1635742012952,"author":{"id":"3560307510640662","authorId":"3560307510640662","name":"Youluyanglu","avatar":"https://static.tigerbbs.com/05bb06bcca1cb9cd5016f4c8230c2803","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560307510640662","authorIdStr":"3560307510640662"},"themes":[],"htmlText":"Tesla will soon go for split again","listText":"Tesla will soon go for split again","text":"Tesla will soon go for split again","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/849880282","repostId":"1164035523","repostType":2,"repost":{"id":"1164035523","kind":"news","pubTimestamp":1635736469,"share":"https://www.laohu8.com/m/news/1164035523?lang=&edition=full","pubTime":"2021-11-01 11:14","market":"us","language":"en","title":"2 Growth Stocks That Could Deliver 1,000% Returns","url":"https://stock-news.laohu8.com/highlight/detail?id=1164035523","media":"Motley Fool","summary":"Thanks to the ongoing innovation revolutions in both the tech and healthcare sectors, shareholders h","content":"<p>Thanks to the ongoing innovation revolutions in both the tech and healthcare sectors, shareholders have been enjoying historic returns on capital over the past decade. For example, the central nervous system disorder drug specialist&nbsp;<b>Axsome Therapeutics</b>, the cancer specialist&nbsp;<b>Exelixis</b>, and the electric car pioneer&nbsp;<b>Tesla</b>&nbsp;have all delivered tenfold returns for investors who bought these names at their low points.</p>\n<p>Which stocks might be the next Axsome, Exelixis, or Tesla from a growth standpoint? The cancer/rare disease specialist&nbsp;<b>Mereo BioPharma Group</b>(NASDAQ:MREO)and the diabetes-focused medical device company&nbsp;<b>Senseonics Holdings</b>(NYSEMKT:SENS)could both be gearing up for a monstrous run higher soon. In fact, these two low-priced&nbsp;healthcare stocks&nbsp;have a decent shot at generating 1,000%-plus returns for their shareholders within the next two to three years.</p>\n<p>Here's a brief overview on the risks and potential rewards associated with each of these promising growth vehicles.</p>\n<p><b>Mereo BioPharma: A bet on the future of immunotherapy</b></p>\n<p>The London-based biopharma Mereo hasn't exactly set the world on fire since its American depository shares (ADS) made their debut on the Nasdaq stock exchange. Keeping with this theme, the biotech's ADSes have lost approximately 65% of their value since April 2019. This steady downward trend shouldn't scare away aggressive investors, however. Mereo's plunging share price, after all, is more about Mr. Market's well-known impatience with clinical-stage biotechs, rather than the company's underlying value proposition.</p>\n<p>What's the scoop? Mereo is a small-cap company with six assets under development for both cancer and rare diseases. However, the one drug candidate that could undoubtedly send the company's shares rocketing higher is the&nbsp;anti-TIGIT therapy&nbsp;known as etigilimab. Several major drug companies, such as&nbsp;<b>BeiGene</b>,<b>Bristol Myers Squibb</b>,<b>Merck</b>, and&nbsp;<b>Roche</b>, have anti-TIGIT therapies under development due to their potential to boost the efficacy and durability of cancer immunotherapy treatments in general. Mereo's etigilimab is currently in a combined phase 1/2 basket study to evaluate its utility as part of combination treament, along with Bristol's megablockbuster checkpoint inhibitor Opdivo, for a variety of solid tumors.</p>\n<p>As things stand now, Mereo's anti-TIGIT candidate is slated to yield top-line data from this basket trial in approximately 18-months from now. During this lengthy interval, however, the drugmaker ought to provide multiple updates on etigilimab's progress, which could turn out to be a series of major catalysts for its share price in the coming months. Another bit of good news is that Mereo's cash runway reportedly extends into 2024. That's key, because it means that the biotech shouldn't have to repeatly tap the public markets for capital over the next year and a half.</p>\n<p>What's the downside risk? Mereo's management team has been open about its desire to partner with larger biopharmas. Etigilimab, for its part, could spark either a high dollar licensing agreement or a full-on buyout within the next two years. So a lot is riding on this single experimental drug. Unfortunately, early stage cancer therapies fail more often than not in the clinic. As a failure in this case would weigh heavily on the biotech's share price, potential investors may want to keep any initial position on the small side.</p>\n<p><b>Senseonic: A rising tide lifts all boats</b></p>\n<p>Senseonics' stock is worth a look by ultra-aggressive investors due to its implantable continuous glucose monitoring (CGM) device franchise known as Eversense. The lowdown is that the CGM market has been growing by over 10%&nbsp;<i>per year</i>&nbsp;over the past five years, according to a report by Grand View Research. What's more, this space is forecast to grow by at least 10% per year over the next five years. That's definitely a favorable trend for a small-cap CGM player like Senseonics.</p>\n<p>So far, Senseonics has only captured a&nbsp;small sliver&nbsp;of this multi-billion dollar medical device market with its Eversense franchise. But the company is hoping to drastically improve its competitive positioning with a potential regulatory approval by the Food and Drug Administration (FDA) for its 180-day version of the Eversense CGM system. The medical device company&nbsp;submitteda regulatory application to the FDA for this proposed product over a year ago. So a decision could come any day now.</p>\n<p>Why does this FDA approval matter? Senseonics' internal projections have the company's top-line rising at a compound annual growth rate of over 70% over the next five years as a result of this key regulatory nod. The long and short of it is that the current 90-day Eversense CGM system isn't particularly competitive in the U.S. against the market-leading devices from&nbsp;<b>DexCom</b>&nbsp;and&nbsp;<b>Abbott Laboratories</b>, respectively. But this longer-lasting version of the device could cause sales to skyrocket in the coming years.</p>\n<p>What's the risk? Senseonics is competing in a jam-packed space against a number of well-capitalized medical-device giants. So there is a chance that this long-awaited FDA approval won't spark a parabolic rise in sales. That's not a knock against Senseonics' CGM system, but rather the harsh reality of competing against healthcare companies with vastly superior resources. Investors shouldn't ignore this potential risk factor.</p>\n<p>All told, Senseonics could be on the verge of a game-changing regulatory event that might prove to be a key inflection point for the company's CGM franchise. If true, this medical device company's stock should turn out to be a downright bargain at these levels.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>2 Growth Stocks That Could Deliver 1,000% Returns</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n2 Growth Stocks That Could Deliver 1,000% Returns\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-01 11:14 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/10/31/2-growth-stocks-that-could-deliver-1000-returns/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Thanks to the ongoing innovation revolutions in both the tech and healthcare sectors, shareholders have been enjoying historic returns on capital over the past decade. For example, the central nervous...</p>\n\n<a href=\"https://www.fool.com/investing/2021/10/31/2-growth-stocks-that-could-deliver-1000-returns/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SENS":"Senseonics Holdings,Inc.","MREO":"Mereo Biopharma Group Plc"},"source_url":"https://www.fool.com/investing/2021/10/31/2-growth-stocks-that-could-deliver-1000-returns/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1164035523","content_text":"Thanks to the ongoing innovation revolutions in both the tech and healthcare sectors, shareholders have been enjoying historic returns on capital over the past decade. For example, the central nervous system disorder drug specialist Axsome Therapeutics, the cancer specialist Exelixis, and the electric car pioneer Tesla have all delivered tenfold returns for investors who bought these names at their low points.\nWhich stocks might be the next Axsome, Exelixis, or Tesla from a growth standpoint? The cancer/rare disease specialist Mereo BioPharma Group(NASDAQ:MREO)and the diabetes-focused medical device company Senseonics Holdings(NYSEMKT:SENS)could both be gearing up for a monstrous run higher soon. In fact, these two low-priced healthcare stocks have a decent shot at generating 1,000%-plus returns for their shareholders within the next two to three years.\nHere's a brief overview on the risks and potential rewards associated with each of these promising growth vehicles.\nMereo BioPharma: A bet on the future of immunotherapy\nThe London-based biopharma Mereo hasn't exactly set the world on fire since its American depository shares (ADS) made their debut on the Nasdaq stock exchange. Keeping with this theme, the biotech's ADSes have lost approximately 65% of their value since April 2019. This steady downward trend shouldn't scare away aggressive investors, however. Mereo's plunging share price, after all, is more about Mr. Market's well-known impatience with clinical-stage biotechs, rather than the company's underlying value proposition.\nWhat's the scoop? Mereo is a small-cap company with six assets under development for both cancer and rare diseases. However, the one drug candidate that could undoubtedly send the company's shares rocketing higher is the anti-TIGIT therapy known as etigilimab. Several major drug companies, such as BeiGene,Bristol Myers Squibb,Merck, and Roche, have anti-TIGIT therapies under development due to their potential to boost the efficacy and durability of cancer immunotherapy treatments in general. Mereo's etigilimab is currently in a combined phase 1/2 basket study to evaluate its utility as part of combination treament, along with Bristol's megablockbuster checkpoint inhibitor Opdivo, for a variety of solid tumors.\nAs things stand now, Mereo's anti-TIGIT candidate is slated to yield top-line data from this basket trial in approximately 18-months from now. During this lengthy interval, however, the drugmaker ought to provide multiple updates on etigilimab's progress, which could turn out to be a series of major catalysts for its share price in the coming months. Another bit of good news is that Mereo's cash runway reportedly extends into 2024. That's key, because it means that the biotech shouldn't have to repeatly tap the public markets for capital over the next year and a half.\nWhat's the downside risk? Mereo's management team has been open about its desire to partner with larger biopharmas. Etigilimab, for its part, could spark either a high dollar licensing agreement or a full-on buyout within the next two years. So a lot is riding on this single experimental drug. Unfortunately, early stage cancer therapies fail more often than not in the clinic. As a failure in this case would weigh heavily on the biotech's share price, potential investors may want to keep any initial position on the small side.\nSenseonic: A rising tide lifts all boats\nSenseonics' stock is worth a look by ultra-aggressive investors due to its implantable continuous glucose monitoring (CGM) device franchise known as Eversense. The lowdown is that the CGM market has been growing by over 10% per year over the past five years, according to a report by Grand View Research. What's more, this space is forecast to grow by at least 10% per year over the next five years. That's definitely a favorable trend for a small-cap CGM player like Senseonics.\nSo far, Senseonics has only captured a small sliver of this multi-billion dollar medical device market with its Eversense franchise. But the company is hoping to drastically improve its competitive positioning with a potential regulatory approval by the Food and Drug Administration (FDA) for its 180-day version of the Eversense CGM system. The medical device company submitteda regulatory application to the FDA for this proposed product over a year ago. So a decision could come any day now.\nWhy does this FDA approval matter? Senseonics' internal projections have the company's top-line rising at a compound annual growth rate of over 70% over the next five years as a result of this key regulatory nod. The long and short of it is that the current 90-day Eversense CGM system isn't particularly competitive in the U.S. against the market-leading devices from DexCom and Abbott Laboratories, respectively. But this longer-lasting version of the device could cause sales to skyrocket in the coming years.\nWhat's the risk? Senseonics is competing in a jam-packed space against a number of well-capitalized medical-device giants. So there is a chance that this long-awaited FDA approval won't spark a parabolic rise in sales. That's not a knock against Senseonics' CGM system, but rather the harsh reality of competing against healthcare companies with vastly superior resources. Investors shouldn't ignore this potential risk factor.\nAll told, Senseonics could be on the verge of a game-changing regulatory event that might prove to be a key inflection point for the company's CGM franchise. If true, this medical device company's stock should turn out to be a downright bargain at these levels.","news_type":1},"isVote":1,"tweetType":1,"viewCount":434,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":857870612,"gmtCreate":1635519638118,"gmtModify":1635519638233,"author":{"id":"3560307510640662","authorId":"3560307510640662","name":"Youluyanglu","avatar":"https://static.tigerbbs.com/05bb06bcca1cb9cd5016f4c8230c2803","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560307510640662","authorIdStr":"3560307510640662"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/CPNG\">$Coupang, Inc.(CPNG)$</a>Loser stock always down seldom up","listText":"<a href=\"https://laohu8.com/S/CPNG\">$Coupang, Inc.(CPNG)$</a>Loser stock always down seldom up","text":"$Coupang, Inc.(CPNG)$Loser stock always down seldom up","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/857870612","isVote":1,"tweetType":1,"viewCount":301,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":854621930,"gmtCreate":1635451859234,"gmtModify":1635451859447,"author":{"id":"3560307510640662","authorId":"3560307510640662","name":"Youluyanglu","avatar":"https://static.tigerbbs.com/05bb06bcca1cb9cd5016f4c8230c2803","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560307510640662","authorIdStr":"3560307510640662"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TSLA\">$Tesla Motors(TSLA)$</a>Donkey ETF everydaytrimming[Spurting]&nbsp;","listText":"<a href=\"https://laohu8.com/S/TSLA\">$Tesla Motors(TSLA)$</a>Donkey ETF everydaytrimming[Spurting]&nbsp;","text":"$Tesla Motors(TSLA)$Donkey ETF everydaytrimming[Spurting]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/854621930","isVote":1,"tweetType":1,"viewCount":170,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":803056668,"gmtCreate":1627397857754,"gmtModify":1631893653628,"author":{"id":"3560307510640662","authorId":"3560307510640662","name":"Youluyanglu","avatar":"https://static.tigerbbs.com/05bb06bcca1cb9cd5016f4c8230c2803","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560307510640662","authorIdStr":"3560307510640662"},"themes":[],"htmlText":"This is a no brained stock to hold and long[Miser]&nbsp;[Miser]&nbsp;[Miser]&nbsp;[Miser]&nbsp;","listText":"This is a no brained stock to hold and long[Miser]&nbsp;[Miser]&nbsp;[Miser]&nbsp;[Miser]&nbsp;","text":"This is a no brained stock to hold and long[Miser] [Miser] [Miser] [Miser]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/803056668","repostId":"1124516451","repostType":4,"repost":{"id":"1124516451","kind":"news","pubTimestamp":1627397263,"share":"https://www.laohu8.com/m/news/1124516451?lang=&edition=full","pubTime":"2021-07-27 22:47","market":"us","language":"en","title":"Tesla Is a Mature Business. Don’t Look Now.","url":"https://stock-news.laohu8.com/highlight/detail?id=1124516451","media":"Barrons","summary":"The electric-vehicle company Tesla reported its best quarterly results ever Monday evening, but investors and analysts are greeting the news with measured optimism—a sign that Tesla is maturing as a company.Tesla  reported $1.45 in adjusted per-share earnings for the second quarter, far higher than the roughly 95 cents analysts were looking for. Sales from regulatory credits—a source of revenue seen as less sustainable than sales of vehicles—-fell, but operating profits rose to record highs beca","content":"<p>The electric-vehicle company&nbsp;Tesla&nbsp;reported its&nbsp;best quarterly results&nbsp;ever Monday evening, but investors and analysts are greeting the news with measured optimism—a sign that Tesla is maturing as a company.</p>\n<p>Tesla (ticker: TSLA)&nbsp;reported&nbsp;$1.45 in adjusted per-share earnings for the second quarter, far higher than the roughly 95 cents analysts were looking for. Sales from regulatory credits—a source of revenue seen as less sustainable than sales of vehicles—-fell, but operating profits rose to record highs because of strong profitability in the automotive division.</p>\n<p>Tesla generates the credits by making more than its fair share of zero- emission cars and sells them to manufacturers that still rely on internal-combustion engines. Pessimists on the stock believe that source of income will dwindle over time.</p>\n<p>The stock, however, was down 1.5% in early trading Tuesday. The&nbsp;S&amp;P 500&nbsp;and&nbsp;Dow Jones Industrial Average,for comparison, had fallen 0.6% and 0.4%, respectively.</p>\n<p>It is a muted reaction to a good quarter, typical of the way stocks of mature businesses behave. Tesla stock moved more than 10% in response to three of the four 2019 quarterly reports. But it rose or fell an average of about 2.5% in response to the 2020 earnings reports.</p>\n<p>The typical 2020 move was a fall in the price in response to news of better-than-expected results. The same thing happened after the release of results for the first quarter of 2021.</p>\n<p>That is another sign of maturity. A small drop in response to better-than-expected results is the typical outcome for stocks. Investors always expect companies to exceed analyst projections, and when they get that result, they “sell the news.”</p>\n<p>The reaction among Wall Street analysts to the latest results is yet another sign of maturity. Mizuho analyst&nbsp;Vijay Rakesh&nbsp;raised his target for Tesla’s stock price by $5 to $825 following the news, for a bump of less than 1%.</p>\n<p>Back in January, RBC analyst&nbsp;Joe Spak&nbsp;raised his target price to $700 a share from $339 after changing how he thought about Tesla’s business. That was a huge target-price change from a large broker.</p>\n<p>Smaller changes in price targets can indicate a business is becoming more stable, and that analysts believe they have a grip on what is happening. That reduces the need for them to dramatically overhaul their views in response to events.</p>\n<p>Overall, the average&nbsp;analyst target price&nbsp;is up about $18, or 3%, in reaction to Monday’s results to about $644 a share. Tesla shares are trading about 1% or 2% above the average analyst target price.</p>\n<p>Target prices generally reflect where analysts think a stock should trade to earn a fair return out into the future. The average target price on stocks in the S&amp;P 500 implies a gain of 7%.</p>\n<p>Even the fact that Tesla is trading around its average analyst target price is a sign of maturity. A year ago, the average target price for Tesla stock was about $225, while the price was above $300.</p>\n<p>Shareholders and bulls on the stock might like a bigger response from the stock when earnings come in strong, but the days of 20% moves, up or down, might be gone for Tesla. That is more evidence that Tesla is here to stay as the world’s most valuable car company.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla Is a Mature Business. Don’t Look Now.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla Is a Mature Business. Don’t Look Now.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-27 22:47 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/tesla-stock-mature-business-51627393369?mod=hp_LEADSUPP_1><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The electric-vehicle company Tesla reported its best quarterly results ever Monday evening, but investors and analysts are greeting the news with measured optimism—a sign that Tesla is maturing as a ...</p>\n\n<a href=\"https://www.barrons.com/articles/tesla-stock-mature-business-51627393369?mod=hp_LEADSUPP_1\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"source_url":"https://www.barrons.com/articles/tesla-stock-mature-business-51627393369?mod=hp_LEADSUPP_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1124516451","content_text":"The electric-vehicle company Tesla reported its best quarterly results ever Monday evening, but investors and analysts are greeting the news with measured optimism—a sign that Tesla is maturing as a company.\nTesla (ticker: TSLA) reported $1.45 in adjusted per-share earnings for the second quarter, far higher than the roughly 95 cents analysts were looking for. Sales from regulatory credits—a source of revenue seen as less sustainable than sales of vehicles—-fell, but operating profits rose to record highs because of strong profitability in the automotive division.\nTesla generates the credits by making more than its fair share of zero- emission cars and sells them to manufacturers that still rely on internal-combustion engines. Pessimists on the stock believe that source of income will dwindle over time.\nThe stock, however, was down 1.5% in early trading Tuesday. The S&P 500 and Dow Jones Industrial Average,for comparison, had fallen 0.6% and 0.4%, respectively.\nIt is a muted reaction to a good quarter, typical of the way stocks of mature businesses behave. Tesla stock moved more than 10% in response to three of the four 2019 quarterly reports. But it rose or fell an average of about 2.5% in response to the 2020 earnings reports.\nThe typical 2020 move was a fall in the price in response to news of better-than-expected results. The same thing happened after the release of results for the first quarter of 2021.\nThat is another sign of maturity. A small drop in response to better-than-expected results is the typical outcome for stocks. Investors always expect companies to exceed analyst projections, and when they get that result, they “sell the news.”\nThe reaction among Wall Street analysts to the latest results is yet another sign of maturity. Mizuho analyst Vijay Rakesh raised his target for Tesla’s stock price by $5 to $825 following the news, for a bump of less than 1%.\nBack in January, RBC analyst Joe Spak raised his target price to $700 a share from $339 after changing how he thought about Tesla’s business. That was a huge target-price change from a large broker.\nSmaller changes in price targets can indicate a business is becoming more stable, and that analysts believe they have a grip on what is happening. That reduces the need for them to dramatically overhaul their views in response to events.\nOverall, the average analyst target price is up about $18, or 3%, in reaction to Monday’s results to about $644 a share. Tesla shares are trading about 1% or 2% above the average analyst target price.\nTarget prices generally reflect where analysts think a stock should trade to earn a fair return out into the future. The average target price on stocks in the S&P 500 implies a gain of 7%.\nEven the fact that Tesla is trading around its average analyst target price is a sign of maturity. A year ago, the average target price for Tesla stock was about $225, while the price was above $300.\nShareholders and bulls on the stock might like a bigger response from the stock when earnings come in strong, but the days of 20% moves, up or down, might be gone for Tesla. That is more evidence that Tesla is here to stay as the world’s most valuable car company.","news_type":1},"isVote":1,"tweetType":1,"viewCount":104,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":807914992,"gmtCreate":1627996262216,"gmtModify":1631893653612,"author":{"id":"3560307510640662","authorId":"3560307510640662","name":"Youluyanglu","avatar":"https://static.tigerbbs.com/05bb06bcca1cb9cd5016f4c8230c2803","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560307510640662","authorIdStr":"3560307510640662"},"themes":[],"htmlText":"What. ePS?&nbsp;","listText":"What. ePS?&nbsp;","text":"What. ePS?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/807914992","repostId":"1124644819","repostType":4,"repost":{"id":"1124644819","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1627995415,"share":"https://www.laohu8.com/m/news/1124644819?lang=&edition=full","pubTime":"2021-08-03 20:56","market":"us","language":"en","title":"Nikola Q2 adj. per-share loss 20 cents, beats loss 30 cents estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=1124644819","media":"Tiger Newspress","summary":"(August 3) Nikola Corporation Q2 adj. per-share loss 20 cents; FactSet loss consensus 30 cents.\nNiko","content":"<p>(August 3)&nbsp;<a href=\"https://laohu8.com/S/NKLA\">Nikola Corporation</a> Q2 adj. per-share loss 20 cents; FactSet loss consensus 30 cents.</p>\n<p>Nikola Q2 per-share loss 36 cents vs. loss 43 cents a year ago.</p>\n<p>Nikola Q2 net loss 143.23&nbsp;bln vs. net loss 115.78&nbsp;bln a year ago.</p>\n<p>Nikola expects to deliver pre-series Tre BEVs for use on public roads in 2H2021.</p>\n<p><img src=\"https://static.tigerbbs.com/d1b990352dadc2e9c043eed4021bc904\" tg-width=\"4392\" tg-height=\"1316\" referrerpolicy=\"no-referrer\">\"During the second quarter Nikola continued to pave the way and solidify our place as a global leader in zero-emissions transportation solutions,” said Mark Russell, Nikola's Chief Executive Officer. “We have had continued success in commissioning and validating the Nikola Tre BEVs, completed both our Ulm, Germany and Phase 0.5 of our Coolidge, Arizona manufacturing facilities, entered into a purchase agreement with Tumim Stone Capital LLC for up to $300 million of Nikola common stock, and acquired a 20% stake in the Wabash Valley Resources clean hydrogen project in West Terra Haute, Indiana.”</p>\n<p><b>Business Outlook</b></p>\n<ul>\n <li>Nikola looks forward to achieving the following milestones in the second half of 2021:</li>\n <li>Deliver pre-series Nikola Tre BEVs for use on public roads hauling customer freight;</li>\n <li>Announce additional fleet testing customers/dealers;</li>\n <li>Break ground on our first commercial hydrogen station and/or centralized hydrogen production facility; and</li>\n <li>Announce additional hydrogen infrastructure/ecosystem partners</li>\n</ul>\n<p><b>Acquired 20% Interest in Wabash Valley Resources</b></p>\n<p>On June 22, Nikola acquired a 20% equity interest in Wabash Valley Resources LLC (WVR), a clean hydrogen project being developed in West Terra Haute, Indiana in exchange for a $54.1 million cash and stock consideration. The project plans to use solid waste byproducts such as petroleum coke combined with biomass to produce clean and sustainable hydrogen. As part of the agreement, Nikola acquired the right to offtake up to 20% of the clean gaseous hydrogen produced at the facility at the anticipated price of less than $1.00 / kg*.</p>\n<p>The offtake agreement with WVR could provide Nikola with approximately 50 tons of hydrogen per day following completion of the plant. This would allow us to supply clean hydrogen in a critical geography.</p>\n<p><b>Closed $300 Million Purchase Agreement with Tumim Stone Capital</b></p>\n<p>On June 11, Nikola entered into a common stock purchase agreement with Tumim Stone Capital LLC (Tumim), obligating Tumim to purchase up to $300 million of Nikola common stock. Under the agreement, Nikola has the right, but not the obligation to sell shares of its common stock to Tumim, subject to certain limitations. Purchase notices may be issued to Tumim over the period commencing from the date of the purchase agreement and ending on the first day of the month following the 36 months anniversary. The shares will be issued at a 3% discount to the three-day forward volume weighted average price (VWAP) from the date a purchase notice is issued.</p>\n<p>This allows us to sell shares to Tumim at our sole discretion and provides us with additional liquidity to execute on our business plan.</p>\n<p><a href=\"https://laohu8.com/S/NKLA\">Nikola Corporation</a>&nbsp;gained&nbsp;nearly&nbsp;2%&nbsp;in&nbsp;premarket&nbsp;trading.</p>\n<p><img src=\"https://static.tigerbbs.com/3254115a823f409c5268ee517389b121\" tg-width=\"946\" tg-height=\"633\" referrerpolicy=\"no-referrer\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nikola Q2 adj. per-share loss 20 cents, beats loss 30 cents estimate</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNikola Q2 adj. per-share loss 20 cents, beats loss 30 cents estimate\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-08-03 20:56</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(August 3)&nbsp;<a href=\"https://laohu8.com/S/NKLA\">Nikola Corporation</a> Q2 adj. per-share loss 20 cents; FactSet loss consensus 30 cents.</p>\n<p>Nikola Q2 per-share loss 36 cents vs. loss 43 cents a year ago.</p>\n<p>Nikola Q2 net loss 143.23&nbsp;bln vs. net loss 115.78&nbsp;bln a year ago.</p>\n<p>Nikola expects to deliver pre-series Tre BEVs for use on public roads in 2H2021.</p>\n<p><img src=\"https://static.tigerbbs.com/d1b990352dadc2e9c043eed4021bc904\" tg-width=\"4392\" tg-height=\"1316\" referrerpolicy=\"no-referrer\">\"During the second quarter Nikola continued to pave the way and solidify our place as a global leader in zero-emissions transportation solutions,” said Mark Russell, Nikola's Chief Executive Officer. “We have had continued success in commissioning and validating the Nikola Tre BEVs, completed both our Ulm, Germany and Phase 0.5 of our Coolidge, Arizona manufacturing facilities, entered into a purchase agreement with Tumim Stone Capital LLC for up to $300 million of Nikola common stock, and acquired a 20% stake in the Wabash Valley Resources clean hydrogen project in West Terra Haute, Indiana.”</p>\n<p><b>Business Outlook</b></p>\n<ul>\n <li>Nikola looks forward to achieving the following milestones in the second half of 2021:</li>\n <li>Deliver pre-series Nikola Tre BEVs for use on public roads hauling customer freight;</li>\n <li>Announce additional fleet testing customers/dealers;</li>\n <li>Break ground on our first commercial hydrogen station and/or centralized hydrogen production facility; and</li>\n <li>Announce additional hydrogen infrastructure/ecosystem partners</li>\n</ul>\n<p><b>Acquired 20% Interest in Wabash Valley Resources</b></p>\n<p>On June 22, Nikola acquired a 20% equity interest in Wabash Valley Resources LLC (WVR), a clean hydrogen project being developed in West Terra Haute, Indiana in exchange for a $54.1 million cash and stock consideration. The project plans to use solid waste byproducts such as petroleum coke combined with biomass to produce clean and sustainable hydrogen. As part of the agreement, Nikola acquired the right to offtake up to 20% of the clean gaseous hydrogen produced at the facility at the anticipated price of less than $1.00 / kg*.</p>\n<p>The offtake agreement with WVR could provide Nikola with approximately 50 tons of hydrogen per day following completion of the plant. This would allow us to supply clean hydrogen in a critical geography.</p>\n<p><b>Closed $300 Million Purchase Agreement with Tumim Stone Capital</b></p>\n<p>On June 11, Nikola entered into a common stock purchase agreement with Tumim Stone Capital LLC (Tumim), obligating Tumim to purchase up to $300 million of Nikola common stock. Under the agreement, Nikola has the right, but not the obligation to sell shares of its common stock to Tumim, subject to certain limitations. Purchase notices may be issued to Tumim over the period commencing from the date of the purchase agreement and ending on the first day of the month following the 36 months anniversary. The shares will be issued at a 3% discount to the three-day forward volume weighted average price (VWAP) from the date a purchase notice is issued.</p>\n<p>This allows us to sell shares to Tumim at our sole discretion and provides us with additional liquidity to execute on our business plan.</p>\n<p><a href=\"https://laohu8.com/S/NKLA\">Nikola Corporation</a>&nbsp;gained&nbsp;nearly&nbsp;2%&nbsp;in&nbsp;premarket&nbsp;trading.</p>\n<p><img src=\"https://static.tigerbbs.com/3254115a823f409c5268ee517389b121\" tg-width=\"946\" tg-height=\"633\" referrerpolicy=\"no-referrer\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NKLA":"Nikola Corporation"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1124644819","content_text":"(August 3) Nikola Corporation Q2 adj. per-share loss 20 cents; FactSet loss consensus 30 cents.\nNikola Q2 per-share loss 36 cents vs. loss 43 cents a year ago.\nNikola Q2 net loss 143.23 bln vs. net loss 115.78 bln a year ago.\nNikola expects to deliver pre-series Tre BEVs for use on public roads in 2H2021.\n\"During the second quarter Nikola continued to pave the way and solidify our place as a global leader in zero-emissions transportation solutions,” said Mark Russell, Nikola's Chief Executive Officer. “We have had continued success in commissioning and validating the Nikola Tre BEVs, completed both our Ulm, Germany and Phase 0.5 of our Coolidge, Arizona manufacturing facilities, entered into a purchase agreement with Tumim Stone Capital LLC for up to $300 million of Nikola common stock, and acquired a 20% stake in the Wabash Valley Resources clean hydrogen project in West Terra Haute, Indiana.”\nBusiness Outlook\n\nNikola looks forward to achieving the following milestones in the second half of 2021:\nDeliver pre-series Nikola Tre BEVs for use on public roads hauling customer freight;\nAnnounce additional fleet testing customers/dealers;\nBreak ground on our first commercial hydrogen station and/or centralized hydrogen production facility; and\nAnnounce additional hydrogen infrastructure/ecosystem partners\n\nAcquired 20% Interest in Wabash Valley Resources\nOn June 22, Nikola acquired a 20% equity interest in Wabash Valley Resources LLC (WVR), a clean hydrogen project being developed in West Terra Haute, Indiana in exchange for a $54.1 million cash and stock consideration. The project plans to use solid waste byproducts such as petroleum coke combined with biomass to produce clean and sustainable hydrogen. As part of the agreement, Nikola acquired the right to offtake up to 20% of the clean gaseous hydrogen produced at the facility at the anticipated price of less than $1.00 / kg*.\nThe offtake agreement with WVR could provide Nikola with approximately 50 tons of hydrogen per day following completion of the plant. This would allow us to supply clean hydrogen in a critical geography.\nClosed $300 Million Purchase Agreement with Tumim Stone Capital\nOn June 11, Nikola entered into a common stock purchase agreement with Tumim Stone Capital LLC (Tumim), obligating Tumim to purchase up to $300 million of Nikola common stock. Under the agreement, Nikola has the right, but not the obligation to sell shares of its common stock to Tumim, subject to certain limitations. Purchase notices may be issued to Tumim over the period commencing from the date of the purchase agreement and ending on the first day of the month following the 36 months anniversary. The shares will be issued at a 3% discount to the three-day forward volume weighted average price (VWAP) from the date a purchase notice is issued.\nThis allows us to sell shares to Tumim at our sole discretion and provides us with additional liquidity to execute on our business plan.\nNikola Corporation gained nearly 2% in premarket trading.","news_type":1},"isVote":1,"tweetType":1,"viewCount":302,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":849880282,"gmtCreate":1635742012878,"gmtModify":1635742012952,"author":{"id":"3560307510640662","authorId":"3560307510640662","name":"Youluyanglu","avatar":"https://static.tigerbbs.com/05bb06bcca1cb9cd5016f4c8230c2803","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560307510640662","authorIdStr":"3560307510640662"},"themes":[],"htmlText":"Tesla will soon go for split again","listText":"Tesla will soon go for split again","text":"Tesla will soon go for split again","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/849880282","repostId":"1164035523","repostType":2,"repost":{"id":"1164035523","kind":"news","pubTimestamp":1635736469,"share":"https://www.laohu8.com/m/news/1164035523?lang=&edition=full","pubTime":"2021-11-01 11:14","market":"us","language":"en","title":"2 Growth Stocks That Could Deliver 1,000% Returns","url":"https://stock-news.laohu8.com/highlight/detail?id=1164035523","media":"Motley Fool","summary":"Thanks to the ongoing innovation revolutions in both the tech and healthcare sectors, shareholders h","content":"<p>Thanks to the ongoing innovation revolutions in both the tech and healthcare sectors, shareholders have been enjoying historic returns on capital over the past decade. For example, the central nervous system disorder drug specialist&nbsp;<b>Axsome Therapeutics</b>, the cancer specialist&nbsp;<b>Exelixis</b>, and the electric car pioneer&nbsp;<b>Tesla</b>&nbsp;have all delivered tenfold returns for investors who bought these names at their low points.</p>\n<p>Which stocks might be the next Axsome, Exelixis, or Tesla from a growth standpoint? The cancer/rare disease specialist&nbsp;<b>Mereo BioPharma Group</b>(NASDAQ:MREO)and the diabetes-focused medical device company&nbsp;<b>Senseonics Holdings</b>(NYSEMKT:SENS)could both be gearing up for a monstrous run higher soon. In fact, these two low-priced&nbsp;healthcare stocks&nbsp;have a decent shot at generating 1,000%-plus returns for their shareholders within the next two to three years.</p>\n<p>Here's a brief overview on the risks and potential rewards associated with each of these promising growth vehicles.</p>\n<p><b>Mereo BioPharma: A bet on the future of immunotherapy</b></p>\n<p>The London-based biopharma Mereo hasn't exactly set the world on fire since its American depository shares (ADS) made their debut on the Nasdaq stock exchange. Keeping with this theme, the biotech's ADSes have lost approximately 65% of their value since April 2019. This steady downward trend shouldn't scare away aggressive investors, however. Mereo's plunging share price, after all, is more about Mr. Market's well-known impatience with clinical-stage biotechs, rather than the company's underlying value proposition.</p>\n<p>What's the scoop? Mereo is a small-cap company with six assets under development for both cancer and rare diseases. However, the one drug candidate that could undoubtedly send the company's shares rocketing higher is the&nbsp;anti-TIGIT therapy&nbsp;known as etigilimab. Several major drug companies, such as&nbsp;<b>BeiGene</b>,<b>Bristol Myers Squibb</b>,<b>Merck</b>, and&nbsp;<b>Roche</b>, have anti-TIGIT therapies under development due to their potential to boost the efficacy and durability of cancer immunotherapy treatments in general. Mereo's etigilimab is currently in a combined phase 1/2 basket study to evaluate its utility as part of combination treament, along with Bristol's megablockbuster checkpoint inhibitor Opdivo, for a variety of solid tumors.</p>\n<p>As things stand now, Mereo's anti-TIGIT candidate is slated to yield top-line data from this basket trial in approximately 18-months from now. During this lengthy interval, however, the drugmaker ought to provide multiple updates on etigilimab's progress, which could turn out to be a series of major catalysts for its share price in the coming months. Another bit of good news is that Mereo's cash runway reportedly extends into 2024. That's key, because it means that the biotech shouldn't have to repeatly tap the public markets for capital over the next year and a half.</p>\n<p>What's the downside risk? Mereo's management team has been open about its desire to partner with larger biopharmas. Etigilimab, for its part, could spark either a high dollar licensing agreement or a full-on buyout within the next two years. So a lot is riding on this single experimental drug. Unfortunately, early stage cancer therapies fail more often than not in the clinic. As a failure in this case would weigh heavily on the biotech's share price, potential investors may want to keep any initial position on the small side.</p>\n<p><b>Senseonic: A rising tide lifts all boats</b></p>\n<p>Senseonics' stock is worth a look by ultra-aggressive investors due to its implantable continuous glucose monitoring (CGM) device franchise known as Eversense. The lowdown is that the CGM market has been growing by over 10%&nbsp;<i>per year</i>&nbsp;over the past five years, according to a report by Grand View Research. What's more, this space is forecast to grow by at least 10% per year over the next five years. That's definitely a favorable trend for a small-cap CGM player like Senseonics.</p>\n<p>So far, Senseonics has only captured a&nbsp;small sliver&nbsp;of this multi-billion dollar medical device market with its Eversense franchise. But the company is hoping to drastically improve its competitive positioning with a potential regulatory approval by the Food and Drug Administration (FDA) for its 180-day version of the Eversense CGM system. The medical device company&nbsp;submitteda regulatory application to the FDA for this proposed product over a year ago. So a decision could come any day now.</p>\n<p>Why does this FDA approval matter? Senseonics' internal projections have the company's top-line rising at a compound annual growth rate of over 70% over the next five years as a result of this key regulatory nod. The long and short of it is that the current 90-day Eversense CGM system isn't particularly competitive in the U.S. against the market-leading devices from&nbsp;<b>DexCom</b>&nbsp;and&nbsp;<b>Abbott Laboratories</b>, respectively. But this longer-lasting version of the device could cause sales to skyrocket in the coming years.</p>\n<p>What's the risk? Senseonics is competing in a jam-packed space against a number of well-capitalized medical-device giants. So there is a chance that this long-awaited FDA approval won't spark a parabolic rise in sales. That's not a knock against Senseonics' CGM system, but rather the harsh reality of competing against healthcare companies with vastly superior resources. Investors shouldn't ignore this potential risk factor.</p>\n<p>All told, Senseonics could be on the verge of a game-changing regulatory event that might prove to be a key inflection point for the company's CGM franchise. If true, this medical device company's stock should turn out to be a downright bargain at these levels.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>2 Growth Stocks That Could Deliver 1,000% Returns</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n2 Growth Stocks That Could Deliver 1,000% Returns\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-01 11:14 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/10/31/2-growth-stocks-that-could-deliver-1000-returns/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Thanks to the ongoing innovation revolutions in both the tech and healthcare sectors, shareholders have been enjoying historic returns on capital over the past decade. For example, the central nervous...</p>\n\n<a href=\"https://www.fool.com/investing/2021/10/31/2-growth-stocks-that-could-deliver-1000-returns/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SENS":"Senseonics Holdings,Inc.","MREO":"Mereo Biopharma Group Plc"},"source_url":"https://www.fool.com/investing/2021/10/31/2-growth-stocks-that-could-deliver-1000-returns/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1164035523","content_text":"Thanks to the ongoing innovation revolutions in both the tech and healthcare sectors, shareholders have been enjoying historic returns on capital over the past decade. For example, the central nervous system disorder drug specialist Axsome Therapeutics, the cancer specialist Exelixis, and the electric car pioneer Tesla have all delivered tenfold returns for investors who bought these names at their low points.\nWhich stocks might be the next Axsome, Exelixis, or Tesla from a growth standpoint? The cancer/rare disease specialist Mereo BioPharma Group(NASDAQ:MREO)and the diabetes-focused medical device company Senseonics Holdings(NYSEMKT:SENS)could both be gearing up for a monstrous run higher soon. In fact, these two low-priced healthcare stocks have a decent shot at generating 1,000%-plus returns for their shareholders within the next two to three years.\nHere's a brief overview on the risks and potential rewards associated with each of these promising growth vehicles.\nMereo BioPharma: A bet on the future of immunotherapy\nThe London-based biopharma Mereo hasn't exactly set the world on fire since its American depository shares (ADS) made their debut on the Nasdaq stock exchange. Keeping with this theme, the biotech's ADSes have lost approximately 65% of their value since April 2019. This steady downward trend shouldn't scare away aggressive investors, however. Mereo's plunging share price, after all, is more about Mr. Market's well-known impatience with clinical-stage biotechs, rather than the company's underlying value proposition.\nWhat's the scoop? Mereo is a small-cap company with six assets under development for both cancer and rare diseases. However, the one drug candidate that could undoubtedly send the company's shares rocketing higher is the anti-TIGIT therapy known as etigilimab. Several major drug companies, such as BeiGene,Bristol Myers Squibb,Merck, and Roche, have anti-TIGIT therapies under development due to their potential to boost the efficacy and durability of cancer immunotherapy treatments in general. Mereo's etigilimab is currently in a combined phase 1/2 basket study to evaluate its utility as part of combination treament, along with Bristol's megablockbuster checkpoint inhibitor Opdivo, for a variety of solid tumors.\nAs things stand now, Mereo's anti-TIGIT candidate is slated to yield top-line data from this basket trial in approximately 18-months from now. During this lengthy interval, however, the drugmaker ought to provide multiple updates on etigilimab's progress, which could turn out to be a series of major catalysts for its share price in the coming months. Another bit of good news is that Mereo's cash runway reportedly extends into 2024. That's key, because it means that the biotech shouldn't have to repeatly tap the public markets for capital over the next year and a half.\nWhat's the downside risk? Mereo's management team has been open about its desire to partner with larger biopharmas. Etigilimab, for its part, could spark either a high dollar licensing agreement or a full-on buyout within the next two years. So a lot is riding on this single experimental drug. Unfortunately, early stage cancer therapies fail more often than not in the clinic. As a failure in this case would weigh heavily on the biotech's share price, potential investors may want to keep any initial position on the small side.\nSenseonic: A rising tide lifts all boats\nSenseonics' stock is worth a look by ultra-aggressive investors due to its implantable continuous glucose monitoring (CGM) device franchise known as Eversense. The lowdown is that the CGM market has been growing by over 10% per year over the past five years, according to a report by Grand View Research. What's more, this space is forecast to grow by at least 10% per year over the next five years. That's definitely a favorable trend for a small-cap CGM player like Senseonics.\nSo far, Senseonics has only captured a small sliver of this multi-billion dollar medical device market with its Eversense franchise. But the company is hoping to drastically improve its competitive positioning with a potential regulatory approval by the Food and Drug Administration (FDA) for its 180-day version of the Eversense CGM system. The medical device company submitteda regulatory application to the FDA for this proposed product over a year ago. So a decision could come any day now.\nWhy does this FDA approval matter? Senseonics' internal projections have the company's top-line rising at a compound annual growth rate of over 70% over the next five years as a result of this key regulatory nod. The long and short of it is that the current 90-day Eversense CGM system isn't particularly competitive in the U.S. against the market-leading devices from DexCom and Abbott Laboratories, respectively. But this longer-lasting version of the device could cause sales to skyrocket in the coming years.\nWhat's the risk? Senseonics is competing in a jam-packed space against a number of well-capitalized medical-device giants. So there is a chance that this long-awaited FDA approval won't spark a parabolic rise in sales. That's not a knock against Senseonics' CGM system, but rather the harsh reality of competing against healthcare companies with vastly superior resources. Investors shouldn't ignore this potential risk factor.\nAll told, Senseonics could be on the verge of a game-changing regulatory event that might prove to be a key inflection point for the company's CGM franchise. If true, this medical device company's stock should turn out to be a downright bargain at these levels.","news_type":1},"isVote":1,"tweetType":1,"viewCount":434,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":809264483,"gmtCreate":1627373588442,"gmtModify":1631893653631,"author":{"id":"3560307510640662","authorId":"3560307510640662","name":"Youluyanglu","avatar":"https://static.tigerbbs.com/05bb06bcca1cb9cd5016f4c8230c2803","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560307510640662","authorIdStr":"3560307510640662"},"themes":[],"htmlText":"Sales surge 98%???? Will stock price surge 10%????","listText":"Sales surge 98%???? Will stock price surge 10%????","text":"Sales surge 98%???? Will stock price surge 10%????","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/809264483","repostId":"1117342739","repostType":4,"repost":{"id":"1117342739","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1627373040,"share":"https://www.laohu8.com/m/news/1117342739?lang=&edition=full","pubTime":"2021-07-27 16:04","market":"us","language":"en","title":"Tesla shares rose more than 1% in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1117342739","media":"Tiger Newspress","summary":"Tesla Inc posted a bigger second-quarter profit than expected on Tuesday thanks to sharply higher sales of its less-expensive electric vehicles, as it raised prices to boost its margins on them.Tesla also cut costs which helped it offset many of the supply chain and microchip shortfalls facing the auto industry.For the first time since late 2019, Tesla profits did not rely on sales of environmental credits to other automakers, a sign of increasing financial health for the manufacturing operation","content":"<p>Tesla Inc posted a bigger second-quarter profit than expected on Tuesday thanks to sharply higher sales of its less-expensive electric vehicles, as it raised prices to boost its margins on them.</p>\n<p>Tesla also cut costs which helped it offset many of the supply chain and microchip shortfalls facing the auto industry.</p>\n<p>For the first time since late 2019, Tesla profits did not rely on sales of environmental credits to other automakers, a sign of increasing financial health for the manufacturing operation. Tesla boosted its performance by cutting features it said were unused or unneeded and raising U.S. vehicle prices.</p>\n<p>Shares of the world’s most valuable automaker rose more&nbsp;than&nbsp;1%&nbsp;in premarket trading.</p>\n<p><img src=\"https://static.tigerbbs.com/979d9a75ec94ed8bf291317150d11d05\" tg-width=\"900\" tg-height=\"639\" width=\"100%\" height=\"auto\"></p>\n<p>In a call with investors and analysts, Tesla executives said that volume production growth will depend on parts availability, and Musk cautioned the shortage of semiconductors will continue.</p>\n<p>“The global chip shortage situation remains quite serious,” Musk said.</p>\n<p>Still, Musk said Tesla expects to launch production this year of the Model Y SUV at factories under construction in Texas and Germany. He said the company expects battery cell suppliers to double production next year.</p>\n<p>Despite the pandemic and the supply chain crisis, Tesla posted record deliveries during the quarter, thanks to sales of cheaper models including Model 3 sedans and Model Ys.</p>\n<p>The carmaker, led by billionaire entrepreneur Elon Musk, said revenue jumped to $11.96 billion from $6.04 billion a year earlier, when its California factory was shut down for more than six weeks due to local lockdown orders to fight the pandemic.</p>\n<p>Analysts had expected revenue of about $11.3 billion, according to IBES data from Refinitiv.</p>\n<p>Excluding items, Tesla posted a profit of $1.45 per share, easily topping analyst expectations for a profit of 98 cents per share.</p>\n<p>Tesla said operating income rose with volume growth and cost reduction, which offset higher supply chain costs, lower regulatory credit revenue and other items including $23 million in losses on investment in cryptocurrency bitcoin.</p>\n<p>Tesla’s profitability has often relied on selling regulatory credits to other automakers, but in the second quarter, Tesla was profitable without these credits for the first time since the end of 2019. Its GAAP net income was $1.14 billion in the second quarter. Revenue from the credits only totaled $354 million.</p>\n<p>“Tesla impressed with its numbers, as most of its revenue came from vehicle sales,” Jesse Cohen, senior analyst at Investing.com, said.</p>\n<p>Carmaker Stellantis expects to achieve its European carbon dioxide (CO2) emissions targets this year without environmental credits bought from Tesla.</p>\n<p>Tesla said it said it has delayed the launch of the Semi truck program to 2022 to focus on starting factories and due to limited availability of battery cells and other parts this year.</p>\n<p>But the company’s new 4680 batteries are not ready for volume production; executives said it was difficult to predict when technological challenges would be resolved.</p>\n<p>In an aside, Musk said he “most likely will not be on earnings calls” going forward to discuss financial results with investors and analysts. These calls have been a colorful quarterly ritual Musk has used for discourses on Tesla technology, or to fire back at rivals or critics.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla shares rose more than 1% in premarket trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla shares rose more than 1% in premarket trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-07-27 16:04</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Tesla Inc posted a bigger second-quarter profit than expected on Tuesday thanks to sharply higher sales of its less-expensive electric vehicles, as it raised prices to boost its margins on them.</p>\n<p>Tesla also cut costs which helped it offset many of the supply chain and microchip shortfalls facing the auto industry.</p>\n<p>For the first time since late 2019, Tesla profits did not rely on sales of environmental credits to other automakers, a sign of increasing financial health for the manufacturing operation. Tesla boosted its performance by cutting features it said were unused or unneeded and raising U.S. vehicle prices.</p>\n<p>Shares of the world’s most valuable automaker rose more&nbsp;than&nbsp;1%&nbsp;in premarket trading.</p>\n<p><img src=\"https://static.tigerbbs.com/979d9a75ec94ed8bf291317150d11d05\" tg-width=\"900\" tg-height=\"639\" width=\"100%\" height=\"auto\"></p>\n<p>In a call with investors and analysts, Tesla executives said that volume production growth will depend on parts availability, and Musk cautioned the shortage of semiconductors will continue.</p>\n<p>“The global chip shortage situation remains quite serious,” Musk said.</p>\n<p>Still, Musk said Tesla expects to launch production this year of the Model Y SUV at factories under construction in Texas and Germany. He said the company expects battery cell suppliers to double production next year.</p>\n<p>Despite the pandemic and the supply chain crisis, Tesla posted record deliveries during the quarter, thanks to sales of cheaper models including Model 3 sedans and Model Ys.</p>\n<p>The carmaker, led by billionaire entrepreneur Elon Musk, said revenue jumped to $11.96 billion from $6.04 billion a year earlier, when its California factory was shut down for more than six weeks due to local lockdown orders to fight the pandemic.</p>\n<p>Analysts had expected revenue of about $11.3 billion, according to IBES data from Refinitiv.</p>\n<p>Excluding items, Tesla posted a profit of $1.45 per share, easily topping analyst expectations for a profit of 98 cents per share.</p>\n<p>Tesla said operating income rose with volume growth and cost reduction, which offset higher supply chain costs, lower regulatory credit revenue and other items including $23 million in losses on investment in cryptocurrency bitcoin.</p>\n<p>Tesla’s profitability has often relied on selling regulatory credits to other automakers, but in the second quarter, Tesla was profitable without these credits for the first time since the end of 2019. Its GAAP net income was $1.14 billion in the second quarter. Revenue from the credits only totaled $354 million.</p>\n<p>“Tesla impressed with its numbers, as most of its revenue came from vehicle sales,” Jesse Cohen, senior analyst at Investing.com, said.</p>\n<p>Carmaker Stellantis expects to achieve its European carbon dioxide (CO2) emissions targets this year without environmental credits bought from Tesla.</p>\n<p>Tesla said it said it has delayed the launch of the Semi truck program to 2022 to focus on starting factories and due to limited availability of battery cells and other parts this year.</p>\n<p>But the company’s new 4680 batteries are not ready for volume production; executives said it was difficult to predict when technological challenges would be resolved.</p>\n<p>In an aside, Musk said he “most likely will not be on earnings calls” going forward to discuss financial results with investors and analysts. These calls have been a colorful quarterly ritual Musk has used for discourses on Tesla technology, or to fire back at rivals or critics.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1117342739","content_text":"Tesla Inc posted a bigger second-quarter profit than expected on Tuesday thanks to sharply higher sales of its less-expensive electric vehicles, as it raised prices to boost its margins on them.\nTesla also cut costs which helped it offset many of the supply chain and microchip shortfalls facing the auto industry.\nFor the first time since late 2019, Tesla profits did not rely on sales of environmental credits to other automakers, a sign of increasing financial health for the manufacturing operation. Tesla boosted its performance by cutting features it said were unused or unneeded and raising U.S. vehicle prices.\nShares of the world’s most valuable automaker rose more than 1% in premarket trading.\n\nIn a call with investors and analysts, Tesla executives said that volume production growth will depend on parts availability, and Musk cautioned the shortage of semiconductors will continue.\n“The global chip shortage situation remains quite serious,” Musk said.\nStill, Musk said Tesla expects to launch production this year of the Model Y SUV at factories under construction in Texas and Germany. He said the company expects battery cell suppliers to double production next year.\nDespite the pandemic and the supply chain crisis, Tesla posted record deliveries during the quarter, thanks to sales of cheaper models including Model 3 sedans and Model Ys.\nThe carmaker, led by billionaire entrepreneur Elon Musk, said revenue jumped to $11.96 billion from $6.04 billion a year earlier, when its California factory was shut down for more than six weeks due to local lockdown orders to fight the pandemic.\nAnalysts had expected revenue of about $11.3 billion, according to IBES data from Refinitiv.\nExcluding items, Tesla posted a profit of $1.45 per share, easily topping analyst expectations for a profit of 98 cents per share.\nTesla said operating income rose with volume growth and cost reduction, which offset higher supply chain costs, lower regulatory credit revenue and other items including $23 million in losses on investment in cryptocurrency bitcoin.\nTesla’s profitability has often relied on selling regulatory credits to other automakers, but in the second quarter, Tesla was profitable without these credits for the first time since the end of 2019. Its GAAP net income was $1.14 billion in the second quarter. Revenue from the credits only totaled $354 million.\n“Tesla impressed with its numbers, as most of its revenue came from vehicle sales,” Jesse Cohen, senior analyst at Investing.com, said.\nCarmaker Stellantis expects to achieve its European carbon dioxide (CO2) emissions targets this year without environmental credits bought from Tesla.\nTesla said it said it has delayed the launch of the Semi truck program to 2022 to focus on starting factories and due to limited availability of battery cells and other parts this year.\nBut the company’s new 4680 batteries are not ready for volume production; executives said it was difficult to predict when technological challenges would be resolved.\nIn an aside, Musk said he “most likely will not be on earnings calls” going forward to discuss financial results with investors and analysts. These calls have been a colorful quarterly ritual Musk has used for discourses on Tesla technology, or to fire back at rivals or critics.","news_type":1},"isVote":1,"tweetType":1,"viewCount":400,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":800474144,"gmtCreate":1627315625888,"gmtModify":1633766180863,"author":{"id":"3560307510640662","authorId":"3560307510640662","name":"Youluyanglu","avatar":"https://static.tigerbbs.com/05bb06bcca1cb9cd5016f4c8230c2803","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560307510640662","authorIdStr":"3560307510640662"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PLTR\">$Palantir Technologies Inc.(PLTR)$</a>Always down most trading day, never up to $30 [Angry]&nbsp;[Angry]&nbsp;[Angry]&nbsp;[Angry]&nbsp;","listText":"<a href=\"https://laohu8.com/S/PLTR\">$Palantir Technologies Inc.(PLTR)$</a>Always down most trading day, never up to $30 [Angry]&nbsp;[Angry]&nbsp;[Angry]&nbsp;[Angry]&nbsp;","text":"$Palantir Technologies Inc.(PLTR)$Always down most trading day, never up to $30 [Angry] [Angry] [Angry] [Angry]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/800474144","isVote":1,"tweetType":1,"viewCount":559,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":879532663,"gmtCreate":1636734917800,"gmtModify":1636734917915,"author":{"id":"3560307510640662","authorId":"3560307510640662","name":"Youluyanglu","avatar":"https://static.tigerbbs.com/05bb06bcca1cb9cd5016f4c8230c2803","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560307510640662","authorIdStr":"3560307510640662"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BNTX\">$BioNTech SE(BNTX)$</a>Is this a falling knife stock?","listText":"<a href=\"https://laohu8.com/S/BNTX\">$BioNTech SE(BNTX)$</a>Is this a falling knife stock?","text":"$BioNTech SE(BNTX)$Is this a falling knife stock?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":1,"link":"https://laohu8.com/post/879532663","isVote":1,"tweetType":1,"viewCount":893,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":851463441,"gmtCreate":1634923042464,"gmtModify":1634923042700,"author":{"id":"3560307510640662","authorId":"3560307510640662","name":"Youluyanglu","avatar":"https://static.tigerbbs.com/05bb06bcca1cb9cd5016f4c8230c2803","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560307510640662","authorIdStr":"3560307510640662"},"themes":[],"htmlText":"Buy and treat as fixed deposit worry free stock","listText":"Buy and treat as fixed deposit worry free stock","text":"Buy and treat as fixed deposit worry free stock","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/851463441","repostId":"2177419115","repostType":2,"repost":{"id":"2177419115","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"T-Reuters","id":"1086160438","head_image":"https://static.tigerbbs.com/a113a995fbbc262262d15a5ce37e7bc5"},"pubTimestamp":1634919955,"share":"https://www.laohu8.com/m/news/2177419115?lang=&edition=full","pubTime":"2021-10-23 00:25","market":"hk","language":"en","title":"S&P Says Tesla Inc. Upgraded To 'BB+' On Solid Demand Prospects And Robust Financial Metrics; Outlook Positive","url":"https://stock-news.laohu8.com/highlight/detail?id=2177419115","media":"T-Reuters","summary":"S&P:S&P Says Tesla Inc. Upgraded To 'Bb+' On Solid Demand Prospects And Robust Financial Metrics; Outlook Positive.S&P, On Tesla, Says Positive Outlook Reflects Our View That Tesla'S Free Operating Cash Flow Generation Will Remain Positive More Consistently.S&P Says Despite Semiconductor Shortages, Other Supply-Related Bottlenecks, Tesla Appears To Have Minimized Production Disruption Versus Most Automakers.S&P Says View On Tesla Also Reflects Outperformance Of Electric Vehicles  So Far This Yea","content":"<html><body><p>S&amp;P:S&amp;P Says Tesla Inc. Upgraded To 'Bb+' On Solid Demand Prospects And Robust Financial Metrics; Outlook Positive.S&amp;P, On Tesla, Says Positive Outlook Reflects Our View That Tesla'S Free Operating Cash Flow Generation Will Remain Positive More Consistently.S&amp;P Says Despite Semiconductor Shortages, Other Supply-Related Bottlenecks, Tesla Appears To Have Minimized Production Disruption Versus Most Automakers.S&amp;P Says View On Tesla Also Reflects Outperformance Of Electric Vehicles (Evs) So Far This Year Globally.S&amp;P Says Key Risks Going Forward Include Access To Supply As Tesla Looks To Raise Cell Capacity And Complete Its Production Ramp-Up To Meet Demand.S&amp;P Says Despite Near-Term Supply Bottlenecks For The Industry, We Expect Tesla Deliveries And Earnings To Remain Strong Over The Next Few Quarters.Further Company Coverage: Tsla.O. ((Reuters.Briefs@Thomsonreuters.Com;)).</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>S&P Says Tesla Inc. Upgraded To 'BB+' On Solid Demand Prospects And Robust Financial Metrics; Outlook Positive</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nS&P Says Tesla Inc. Upgraded To 'BB+' On Solid Demand Prospects And Robust Financial Metrics; Outlook Positive\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086160438\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a113a995fbbc262262d15a5ce37e7bc5);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">T-Reuters </p>\n<p class=\"h-time\">2021-10-23 00:25</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>S&amp;P:S&amp;P Says Tesla Inc. Upgraded To 'Bb+' On Solid Demand Prospects And Robust Financial Metrics; Outlook Positive.S&amp;P, On Tesla, Says Positive Outlook Reflects Our View That Tesla'S Free Operating Cash Flow Generation Will Remain Positive More Consistently.S&amp;P Says Despite Semiconductor Shortages, Other Supply-Related Bottlenecks, Tesla Appears To Have Minimized Production Disruption Versus Most Automakers.S&amp;P Says View On Tesla Also Reflects Outperformance Of Electric Vehicles (Evs) So Far This Year Globally.S&amp;P Says Key Risks Going Forward Include Access To Supply As Tesla Looks To Raise Cell Capacity And Complete Its Production Ramp-Up To Meet Demand.S&amp;P Says Despite Near-Term Supply Bottlenecks For The Industry, We Expect Tesla Deliveries And Earnings To Remain Strong Over The Next Few Quarters.Further Company Coverage: Tsla.O. ((Reuters.Briefs@Thomsonreuters.Com;)).</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"FWRG":"First Watch Restaurant Group, Inc.","CRCT":"Cricut, Inc.","OLPX":"Olaplex Holdings, Inc.","HCTI":"Healthcare Triangle, Inc.","TSLA":"特斯拉","TERN":"Terns Pharmaceuticals, Inc."},"source_url":"https://www.trkd.thomsonreuters.com","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2177419115","content_text":"S&P:S&P Says Tesla Inc. Upgraded To 'Bb+' On Solid Demand Prospects And Robust Financial Metrics; Outlook Positive.S&P, On Tesla, Says Positive Outlook Reflects Our View That Tesla'S Free Operating Cash Flow Generation Will Remain Positive More Consistently.S&P Says Despite Semiconductor Shortages, Other Supply-Related Bottlenecks, Tesla Appears To Have Minimized Production Disruption Versus Most Automakers.S&P Says View On Tesla Also Reflects Outperformance Of Electric Vehicles (Evs) So Far This Year Globally.S&P Says Key Risks Going Forward Include Access To Supply As Tesla Looks To Raise Cell Capacity And Complete Its Production Ramp-Up To Meet Demand.S&P Says Despite Near-Term Supply Bottlenecks For The Industry, We Expect Tesla Deliveries And Earnings To Remain Strong Over The Next Few Quarters.Further Company Coverage: Tsla.O. ((Reuters.Briefs@Thomsonreuters.Com;)).","news_type":1},"isVote":1,"tweetType":1,"viewCount":136,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":865058286,"gmtCreate":1632925862246,"gmtModify":1632925862458,"author":{"id":"3560307510640662","authorId":"3560307510640662","name":"Youluyanglu","avatar":"https://static.tigerbbs.com/05bb06bcca1cb9cd5016f4c8230c2803","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560307510640662","authorIdStr":"3560307510640662"},"themes":[],"htmlText":"But yesterday drop more then today little increase [Spurting]&nbsp;[Spurting]&nbsp;[Spurting]&nbsp;","listText":"But yesterday drop more then today little increase [Spurting]&nbsp;[Spurting]&nbsp;[Spurting]&nbsp;","text":"But yesterday drop more then today little increase [Spurting] [Spurting] [Spurting]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/865058286","repostId":"1190233990","repostType":4,"repost":{"id":"1190233990","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1632925635,"share":"https://www.laohu8.com/m/news/1190233990?lang=&edition=full","pubTime":"2021-09-29 22:27","market":"us","language":"en","title":"Pharmaceutical stocks rallied in morning trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1190233990","media":"Tiger Newspress","summary":"Pharmaceutical stocks rallied in morning trading.Pfizer,BioNTech SE,Eli Lilly,Merck,Moderna,AstraZen","content":"<p>Pharmaceutical stocks rallied in morning trading.Pfizer,BioNTech SE,Eli Lilly,Merck,Moderna,AstraZeneca&nbsp;and&nbsp;Sanofi&nbsp;climbed&nbsp;between 0.5% and 3%.</p>\n<p><img src=\"https://static.tigerbbs.com/30e27c112e85fc577e71ea58a8ac6216\" tg-width=\"407\" tg-height=\"716\" referrerpolicy=\"no-referrer\"></p>\n<p>Pfizer’s covid-19 vaccine for kids may not be FDA authorized before november.</p>\n<p>Citi analyst Andrew Baum upgraded shares of Ely Lilly and Co&nbsp;to Buy and raised the price target.</p>\n<p>Merck says its covid-19 antiviral pill is cctive against variants.</p>\n<p>AstraZeneca buys rare disease drugmaker Caelum in potential $500 mln deal.</p>\n<p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pharmaceutical stocks rallied in morning trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPharmaceutical stocks rallied in morning trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-09-29 22:27</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Pharmaceutical stocks rallied in morning trading.Pfizer,BioNTech SE,Eli Lilly,Merck,Moderna,AstraZeneca&nbsp;and&nbsp;Sanofi&nbsp;climbed&nbsp;between 0.5% and 3%.</p>\n<p><img src=\"https://static.tigerbbs.com/30e27c112e85fc577e71ea58a8ac6216\" tg-width=\"407\" tg-height=\"716\" referrerpolicy=\"no-referrer\"></p>\n<p>Pfizer’s covid-19 vaccine for kids may not be FDA authorized before november.</p>\n<p>Citi analyst Andrew Baum upgraded shares of Ely Lilly and Co&nbsp;to Buy and raised the price target.</p>\n<p>Merck says its covid-19 antiviral pill is cctive against variants.</p>\n<p>AstraZeneca buys rare disease drugmaker Caelum in potential $500 mln deal.</p>\n<p></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNTX":"BioNTech SE","PFE":"辉瑞"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1190233990","content_text":"Pharmaceutical stocks rallied in morning trading.Pfizer,BioNTech SE,Eli Lilly,Merck,Moderna,AstraZeneca and Sanofi climbed between 0.5% and 3%.\n\nPfizer’s covid-19 vaccine for kids may not be FDA authorized before november.\nCiti analyst Andrew Baum upgraded shares of Ely Lilly and Co to Buy and raised the price target.\nMerck says its covid-19 antiviral pill is cctive against variants.\nAstraZeneca buys rare disease drugmaker Caelum in potential $500 mln deal.","news_type":1},"isVote":1,"tweetType":1,"viewCount":246,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":125980656,"gmtCreate":1624641103175,"gmtModify":1633950135573,"author":{"id":"3560307510640662","authorId":"3560307510640662","name":"Youluyanglu","avatar":"https://static.tigerbbs.com/05bb06bcca1cb9cd5016f4c8230c2803","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560307510640662","authorIdStr":"3560307510640662"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TSLA\">$Tesla Motors(TSLA)$</a>Bitcoin down Tesla down damn unlucky coin[Sad]&nbsp;[Sad]&nbsp;[Sad]&nbsp;[Sad]&nbsp;[Sad]&nbsp;[Sad]&nbsp;[Speechless]&nbsp;[Sad]&nbsp;[Sad]&nbsp;[Sad]&nbsp;","listText":"<a href=\"https://laohu8.com/S/TSLA\">$Tesla Motors(TSLA)$</a>Bitcoin down Tesla down damn unlucky coin[Sad]&nbsp;[Sad]&nbsp;[Sad]&nbsp;[Sad]&nbsp;[Sad]&nbsp;[Sad]&nbsp;[Speechless]&nbsp;[Sad]&nbsp;[Sad]&nbsp;[Sad]&nbsp;","text":"$Tesla Motors(TSLA)$Bitcoin down Tesla down damn unlucky coin[Sad] [Sad] [Sad] [Sad] [Sad] [Sad] [Speechless] [Sad] [Sad] [Sad]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/125980656","isVote":1,"tweetType":1,"viewCount":183,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":864253013,"gmtCreate":1633114410754,"gmtModify":1633114411095,"author":{"id":"3560307510640662","authorId":"3560307510640662","name":"Youluyanglu","avatar":"https://static.tigerbbs.com/05bb06bcca1cb9cd5016f4c8230c2803","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560307510640662","authorIdStr":"3560307510640662"},"themes":[],"htmlText":"Her ETF is under performance after bill haung and her partner left .","listText":"Her ETF is under performance after bill haung and her partner left .","text":"Her ETF is under performance after bill haung and her partner left .","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/864253013","repostId":"2172295185","repostType":4,"isVote":1,"tweetType":1,"viewCount":143,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":180035438,"gmtCreate":1623163742524,"gmtModify":1634036247505,"author":{"id":"3560307510640662","authorId":"3560307510640662","name":"Youluyanglu","avatar":"https://static.tigerbbs.com/05bb06bcca1cb9cd5016f4c8230c2803","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560307510640662","authorIdStr":"3560307510640662"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TSLA\">$Tesla Motors(TSLA)$</a>Bad news Tesla down good news Tesla still down. Bitcoin up Tesla down Bitcoin down Tesla down again","listText":"<a href=\"https://laohu8.com/S/TSLA\">$Tesla Motors(TSLA)$</a>Bad news Tesla down good news Tesla still down. Bitcoin up Tesla down Bitcoin down Tesla down again","text":"$Tesla Motors(TSLA)$Bad news Tesla down good news Tesla still down. Bitcoin up Tesla down Bitcoin down Tesla down again","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/180035438","isVote":1,"tweetType":1,"viewCount":535,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":807917081,"gmtCreate":1627996361743,"gmtModify":1631893653613,"author":{"id":"3560307510640662","authorId":"3560307510640662","name":"Youluyanglu","avatar":"https://static.tigerbbs.com/05bb06bcca1cb9cd5016f4c8230c2803","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560307510640662","authorIdStr":"3560307510640662"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TSLA\">$Tesla Motors(TSLA)$</a>Go for split like last year is best. Tesla stock is too expensive for retail investors now [LOL]&nbsp;[LOL]&nbsp;[LOL]&nbsp;","listText":"<a href=\"https://laohu8.com/S/TSLA\">$Tesla Motors(TSLA)$</a>Go for split like last year is best. Tesla stock is too expensive for retail investors now [LOL]&nbsp;[LOL]&nbsp;[LOL]&nbsp;","text":"$Tesla Motors(TSLA)$Go for split like last year is best. Tesla stock is too expensive for retail investors now [LOL] [LOL] [LOL]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/807917081","isVote":1,"tweetType":1,"viewCount":441,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":800735732,"gmtCreate":1627317921826,"gmtModify":1633766161721,"author":{"id":"3560307510640662","authorId":"3560307510640662","name":"Youluyanglu","avatar":"https://static.tigerbbs.com/05bb06bcca1cb9cd5016f4c8230c2803","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560307510640662","authorIdStr":"3560307510640662"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PDD\">$Pinduoduo Inc.(PDD)$</a>Will drop to $60????","listText":"<a href=\"https://laohu8.com/S/PDD\">$Pinduoduo Inc.(PDD)$</a>Will drop to $60????","text":"$Pinduoduo Inc.(PDD)$Will drop to $60????","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/800735732","isVote":1,"tweetType":1,"viewCount":1772,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3475320740708771","authorId":"3475320740708771","name":"troubleboy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"idStr":"3475320740708771","authorIdStr":"3475320740708771"},"content":"把零去掉！","text":"把零去掉！","html":"把零去掉！"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":166717029,"gmtCreate":1624025101861,"gmtModify":1631886774653,"author":{"id":"3560307510640662","authorId":"3560307510640662","name":"Youluyanglu","avatar":"https://static.tigerbbs.com/05bb06bcca1cb9cd5016f4c8230c2803","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560307510640662","authorIdStr":"3560307510640662"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PTRA\">$Proterra Inc.(PTRA)$</a>Why so weak after gopublic?","listText":"<a href=\"https://laohu8.com/S/PTRA\">$Proterra Inc.(PTRA)$</a>Why so weak after gopublic?","text":"$Proterra Inc.(PTRA)$Why so weak after gopublic?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/166717029","isVote":1,"tweetType":1,"viewCount":423,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":860760407,"gmtCreate":1632214568709,"gmtModify":1632802026635,"author":{"id":"3560307510640662","authorId":"3560307510640662","name":"Youluyanglu","avatar":"https://static.tigerbbs.com/05bb06bcca1cb9cd5016f4c8230c2803","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560307510640662","authorIdStr":"3560307510640662"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ARKG\">$ARK Genomic Revolution Multi-Sector ETF(ARKG)$</a>Worst genomic etf 2021","listText":"<a href=\"https://laohu8.com/S/ARKG\">$ARK Genomic Revolution Multi-Sector ETF(ARKG)$</a>Worst genomic etf 2021","text":"$ARK Genomic Revolution Multi-Sector ETF(ARKG)$Worst genomic etf 2021","images":[{"img":"https://static.tigerbbs.com/995fc94b7bd34e97d551db9379ac0dd8","width":"750","height":"1068"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/860760407","isVote":1,"tweetType":1,"viewCount":80,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":886954966,"gmtCreate":1631545689255,"gmtModify":1631885647477,"author":{"id":"3560307510640662","authorId":"3560307510640662","name":"Youluyanglu","avatar":"https://static.tigerbbs.com/05bb06bcca1cb9cd5016f4c8230c2803","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560307510640662","authorIdStr":"3560307510640662"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ARKG\">$ARK Genomic Revolution Multi-Sector ETF(ARKG)$</a>What is the growth 2021&nbsp;YTD?","listText":"<a href=\"https://laohu8.com/S/ARKG\">$ARK Genomic Revolution Multi-Sector ETF(ARKG)$</a>What is the growth 2021&nbsp;YTD?","text":"$ARK Genomic Revolution Multi-Sector ETF(ARKG)$What is the growth 2021 YTD?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":1,"link":"https://laohu8.com/post/886954966","isVote":1,"tweetType":1,"viewCount":143,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":818422778,"gmtCreate":1630430279394,"gmtModify":1631883945876,"author":{"id":"3560307510640662","authorId":"3560307510640662","name":"Youluyanglu","avatar":"https://static.tigerbbs.com/05bb06bcca1cb9cd5016f4c8230c2803","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560307510640662","authorIdStr":"3560307510640662"},"themes":[],"htmlText":"<a target=\"_blank\" href=\"https://laohu8.com/S/MRNA\">$Moderna, Inc.(MRNA)$</a> patience","listText":"<a target=\"_blank\" href=\"https://laohu8.com/S/MRNA\">$Moderna, Inc.(MRNA)$</a> patience","text":"$Moderna, Inc.(MRNA)$ patience","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/818422778","isVote":1,"tweetType":1,"viewCount":90,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":800477761,"gmtCreate":1627315732153,"gmtModify":1631884679631,"author":{"id":"3560307510640662","authorId":"3560307510640662","name":"Youluyanglu","avatar":"https://static.tigerbbs.com/05bb06bcca1cb9cd5016f4c8230c2803","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560307510640662","authorIdStr":"3560307510640662"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SENS\">$Senseonics(SENS)$</a>Already weak for months where is the catalyst [Smug]&nbsp;[Smug]&nbsp;[Smug]&nbsp;[Smug]&nbsp;[Smug]&nbsp;","listText":"<a href=\"https://laohu8.com/S/SENS\">$Senseonics(SENS)$</a>Already weak for months where is the catalyst [Smug]&nbsp;[Smug]&nbsp;[Smug]&nbsp;[Smug]&nbsp;[Smug]&nbsp;","text":"$Senseonics(SENS)$Already weak for months where is the catalyst [Smug] [Smug] [Smug] [Smug] [Smug]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/800477761","isVote":1,"tweetType":1,"viewCount":1038,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":176677146,"gmtCreate":1626883342885,"gmtModify":1633770091531,"author":{"id":"3560307510640662","authorId":"3560307510640662","name":"Youluyanglu","avatar":"https://static.tigerbbs.com/05bb06bcca1cb9cd5016f4c8230c2803","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560307510640662","authorIdStr":"3560307510640662"},"themes":[],"htmlText":"Make no sense[Smug]&nbsp;","listText":"Make no sense[Smug]&nbsp;","text":"Make no sense[Smug]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/176677146","repostId":"1161684365","repostType":4,"isVote":1,"tweetType":1,"viewCount":10,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":601070729,"gmtCreate":1638463935686,"gmtModify":1638463935807,"author":{"id":"3560307510640662","authorId":"3560307510640662","name":"Youluyanglu","avatar":"https://static.tigerbbs.com/05bb06bcca1cb9cd5016f4c8230c2803","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560307510640662","authorIdStr":"3560307510640662"},"themes":[],"htmlText":"Why didn’t you bought Charlie munger’s baba stock???","listText":"Why didn’t you bought Charlie munger’s baba stock???","text":"Why didn’t you bought Charlie munger’s baba stock???","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/601070729","repostId":"2188124518","repostType":4,"repost":{"id":"2188124518","kind":"highlight","pubTimestamp":1638451761,"share":"https://www.laohu8.com/m/news/2188124518?lang=&edition=full","pubTime":"2021-12-02 21:29","market":"us","language":"en","title":"3 Warren Buffett Stocks I'd Buy in December Without Any Hesitation","url":"https://stock-news.laohu8.com/highlight/detail?id=2188124518","media":"Motley Fool","summary":"All three should be surefire winners over the long term.","content":"<p>Warren Buffett isn't as big of a winner as he once was. The legendary investor routinely beat the <b>S&amp;P 500</b>'s performance throughout much of his career. So far this year, though, <b>Berkshire Hathaway</b>'s (NYSE:BRK.A) (NYSE:BRK.B) gains are lagging behind the index.</p>\n<p>Many of the stocks in Berkshire's portfolio have generated strong year-to-date returns, but not all of them. Regardless of how they've performed recently, some Berkshire holdings remain especially attractive over the long term.&nbsp;Here are three Buffett stocks I'd buy in December without any reservations.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/1273c4c1c74f572c86d5fa1d36534c37\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: The Motley Fool.</span></p>\n<h2>1. Amazon.com</h2>\n<p><b>Amazon.com</b> (NASDAQ:AMZN) belongs in the group of Buffett's laggards. Shares of the internet giant have risen only around 8% this year, well behind Berkshire's overall performance. However, there are few stocks of large companies that have as clear of a growth runway as Amazon does.</p>\n<p>Let's start with the near term. Amazon expects record holiday sales in the fourth quarter of $135 billion. Twelve-digit quarterly revenue has become standard fare for the company. Amazon is investing heavily in adding capacity to support its fulfillment operations. That's an obvious sign that the company anticipates significant growth in the future.</p>\n<p>This isn't a surprise. E-commerce sales in the U.S. made up only 13% of total retail sales in the third quarter. Amazon still has a huge growth opportunity in this core market.</p>\n<p>But e-commerce is just <a href=\"https://laohu8.com/S/AONE.U\">one</a> growth driver for the company. Amazon Web Services remains the biggest cloud hosting business in the world and continues to grow rapidly. The company's advertising business is picking up major momentum. Amazon's healthcare moves in online pharmacy and telehealth could also pay off nicely. I don't see this stock staying a laggard for very long.</p>\n<h2>2. Apple</h2>\n<p>Not all of the FAANG stocks are underperformers this year. Shares of&nbsp;<b>Apple</b> (NASDAQ:AAPL) have soared more than 20%. And that impressive gain came despite the company posting disappointing Q3 results.</p>\n<p>Investors are focusing on the future with Apple -- just as they should be. The company continues to ride the wave of 5G adoption. Its iPhone sales seem likely to reach record levels this holiday season unless supply chain issues serve as a damper. The 5G \"supercycle\" could keep going throughout 2022 and even beyond.</p>\n<p>Apple could enjoy even stronger growth going forward. The company could unveil its augmented reality (AR) headset next year, and it's working on AR glasses. Apple is also reportedly developing a self-driving electric car.</p>\n<p>Buffett likes Apple so much that it's the largest holding in Berkshire's portfolio. I fully expect that the stock will keep up its winning ways for years to come.</p>\n<h2>3. Mastercard</h2>\n<p>You might be at least a little surprised that I've included&nbsp;<b>Mastercard</b> (NYSE:MA) on this list. After all, the stock has fallen more than 10% so far in 2021. But there's still a lot to like about Mastercard.</p>\n<p>The company makes money from transaction fees every time one of its credit cards is used to make a purchase. With the rise of e-commerce and the shift away from cash with in-store purchases, Mastercard's credit cards will almost certainly be used a lot more in the future.</p>\n<p>Although Mastercard is already a global company, it still has plenty of growth opportunities in developing regions. For example, Mastercard's recent acquisition of fintech company Arcus FI should help boost its presence in the Latin American market.</p>\n<p>Two potential growth drivers for Mastercard might not receive as much attention as they deserve. The company's \"buy now, pay later\" program is picking up momentum. Mastercard is also expanding its cryptocurrency support, partnering with three cryptocurrency providers in the Asia Pacific region to launch crypto-funded Mastercard payment cards.</p>\n<p>It's possible that the emergence of the omicron variant could create some temporary headwinds for Mastercard if businesses experience disruptions. However, this Buffett stock should be a big winner over the long run.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Warren Buffett Stocks I'd Buy in December Without Any Hesitation</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Warren Buffett Stocks I'd Buy in December Without Any Hesitation\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-02 21:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/02/3-warren-buffett-stocks-id-buy-in-december-without/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Warren Buffett isn't as big of a winner as he once was. The legendary investor routinely beat the S&P 500's performance throughout much of his career. So far this year, though, Berkshire Hathaway's (...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/02/3-warren-buffett-stocks-id-buy-in-december-without/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4507":"流媒体概念","BK4534":"瑞士信贷持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4566":"资本集团","BK4524":"宅经济概念","BRK.A":"伯克希尔","BK4535":"淡马锡持仓","BK4559":"巴菲特持仓","BK4527":"明星科技股","BRK.B":"伯克希尔B","BK4501":"段永平概念","BK4538":"云计算","BK4550":"红杉资本持仓","AMZN":"亚马逊","BK4503":"景林资产持仓","BK4122":"互联网与直销零售","BK4551":"寇图资本持仓","AR":"Antero Resources Corp","BK4561":"索罗斯持仓","AAPL":"苹果","BK4505":"高瓴资本持仓","BK4548":"巴美列捷福持仓","BK4170":"电脑硬件、储存设备及电脑周边","BK4176":"多领域控股","BK4213":"石油与天然气的勘探与生产","BK4554":"元宇宙及AR概念","BK4106":"数据处理与外包服务","BK4532":"文艺复兴科技持仓","BK4515":"5G概念","MA":"万事达","BK4553":"喜马拉雅资本持仓"},"source_url":"https://www.fool.com/investing/2021/12/02/3-warren-buffett-stocks-id-buy-in-december-without/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2188124518","content_text":"Warren Buffett isn't as big of a winner as he once was. The legendary investor routinely beat the S&P 500's performance throughout much of his career. So far this year, though, Berkshire Hathaway's (NYSE:BRK.A) (NYSE:BRK.B) gains are lagging behind the index.\nMany of the stocks in Berkshire's portfolio have generated strong year-to-date returns, but not all of them. Regardless of how they've performed recently, some Berkshire holdings remain especially attractive over the long term. Here are three Buffett stocks I'd buy in December without any reservations.\nImage source: The Motley Fool.\n1. Amazon.com\nAmazon.com (NASDAQ:AMZN) belongs in the group of Buffett's laggards. Shares of the internet giant have risen only around 8% this year, well behind Berkshire's overall performance. However, there are few stocks of large companies that have as clear of a growth runway as Amazon does.\nLet's start with the near term. Amazon expects record holiday sales in the fourth quarter of $135 billion. Twelve-digit quarterly revenue has become standard fare for the company. Amazon is investing heavily in adding capacity to support its fulfillment operations. That's an obvious sign that the company anticipates significant growth in the future.\nThis isn't a surprise. E-commerce sales in the U.S. made up only 13% of total retail sales in the third quarter. Amazon still has a huge growth opportunity in this core market.\nBut e-commerce is just one growth driver for the company. Amazon Web Services remains the biggest cloud hosting business in the world and continues to grow rapidly. The company's advertising business is picking up major momentum. Amazon's healthcare moves in online pharmacy and telehealth could also pay off nicely. I don't see this stock staying a laggard for very long.\n2. Apple\nNot all of the FAANG stocks are underperformers this year. Shares of Apple (NASDAQ:AAPL) have soared more than 20%. And that impressive gain came despite the company posting disappointing Q3 results.\nInvestors are focusing on the future with Apple -- just as they should be. The company continues to ride the wave of 5G adoption. Its iPhone sales seem likely to reach record levels this holiday season unless supply chain issues serve as a damper. The 5G \"supercycle\" could keep going throughout 2022 and even beyond.\nApple could enjoy even stronger growth going forward. The company could unveil its augmented reality (AR) headset next year, and it's working on AR glasses. Apple is also reportedly developing a self-driving electric car.\nBuffett likes Apple so much that it's the largest holding in Berkshire's portfolio. I fully expect that the stock will keep up its winning ways for years to come.\n3. Mastercard\nYou might be at least a little surprised that I've included Mastercard (NYSE:MA) on this list. After all, the stock has fallen more than 10% so far in 2021. But there's still a lot to like about Mastercard.\nThe company makes money from transaction fees every time one of its credit cards is used to make a purchase. With the rise of e-commerce and the shift away from cash with in-store purchases, Mastercard's credit cards will almost certainly be used a lot more in the future.\nAlthough Mastercard is already a global company, it still has plenty of growth opportunities in developing regions. For example, Mastercard's recent acquisition of fintech company Arcus FI should help boost its presence in the Latin American market.\nTwo potential growth drivers for Mastercard might not receive as much attention as they deserve. The company's \"buy now, pay later\" program is picking up momentum. Mastercard is also expanding its cryptocurrency support, partnering with three cryptocurrency providers in the Asia Pacific region to launch crypto-funded Mastercard payment cards.\nIt's possible that the emergence of the omicron variant could create some temporary headwinds for Mastercard if businesses experience disruptions. However, this Buffett stock should be a big winner over the long run.","news_type":1},"isVote":1,"tweetType":1,"viewCount":407,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}